<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" xml:lang="en" dtd-version="1.4"><processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats"><restricted-by>pmc</restricted-by></processing-meta><front><journal-meta><journal-id journal-id-type="nlm-ta">Sci Rep</journal-id><journal-id journal-id-type="iso-abbrev">Sci Rep</journal-id><journal-id journal-id-type="pmc-domain-id">1579</journal-id><journal-id journal-id-type="pmc-domain">scirep</journal-id><journal-title-group><journal-title>Scientific Reports</journal-title></journal-title-group><issn pub-type="epub">2045-2322</issn><publisher><publisher-name>Nature Publishing Group</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12241595</article-id><article-id pub-id-type="pmcid-ver">PMC12241595.1</article-id><article-id pub-id-type="pmcaid">12241595</article-id><article-id pub-id-type="pmcaiid">12241595</article-id><article-id pub-id-type="pmid">40634546</article-id><article-id pub-id-type="doi">10.1038/s41598-025-10240-6</article-id><article-id pub-id-type="publisher-id">10240</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>InterPAD is a database of drug-drug interaction between phytochemicals and anticancer drugs</article-title></title-group><contrib-group><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Zhang</surname><given-names initials="A">Aili</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" equal-contrib="yes"><name name-style="western"><surname>Sun</surname><given-names initials="X">Xueni</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Wu</surname><given-names initials="Q">Qibiao</given-names></name><xref ref-type="aff" rid="Aff1">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Jiang</surname><given-names initials="H">Haiyang</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Xu</surname><given-names initials="L">Lihui</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gao</surname><given-names initials="Q">Quan</given-names></name><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Yang</surname><given-names initials="Z">Zijing</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Zhu</surname><given-names initials="S">Sisi</given-names></name><xref ref-type="aff" rid="Aff2">2</xref></contrib><contrib contrib-type="author" corresp="yes"><name name-style="western"><surname>Sui</surname><given-names initials="X">Xinbing</given-names></name><address><email>suilab@hznu.edu.cn</email></address><xref ref-type="aff" rid="Aff1">1</xref><xref ref-type="aff" rid="Aff2">2</xref></contrib><aff id="Aff1"><label>1</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/03jqs2n27</institution-id><institution-id institution-id-type="GRID">grid.259384.1</institution-id><institution-id institution-id-type="ISNI">0000 0000 8945 4455</institution-id><institution>State Key Laboratory of Quality Research in Chinese Medicines, Faculty of Chinese Medicine, </institution><institution>Macau University of Science and Technology, </institution></institution-wrap>Macau, People&#8217;s Republic of China </aff><aff id="Aff2"><label>2</label><institution-wrap><institution-id institution-id-type="ROR">https://ror.org/014v1mr15</institution-id><institution-id institution-id-type="GRID">grid.410595.c</institution-id><institution-id institution-id-type="ISNI">0000 0001 2230 9154</institution-id><institution>School of Pharmacy, </institution><institution>Hangzhou Normal University, </institution></institution-wrap>Hangzhou, 311121 Zhejiang People&#8217;s Republic of China </aff></contrib-group><pub-date pub-type="epub"><day>9</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="collection"><year>2025</year></pub-date><volume>15</volume><issue-id pub-id-type="pmc-issue-id">478255</issue-id><elocation-id>24616</elocation-id><history><date date-type="received"><day>20</day><month>3</month><year>2025</year></date><date date-type="accepted"><day>2</day><month>7</month><year>2025</year></date></history><pub-history><event event-type="pmc-release"><date><day>09</day><month>07</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>10</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-11 00:25:15.380"><day>11</day><month>07</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2025</copyright-statement><copyright-year>2025</copyright-year><license><ali:license_ref specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p><bold>Open Access</bold> This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article&#8217;s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article&#8217;s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">http://creativecommons.org/licenses/by-nc-nd/4.0/</ext-link>.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="41598_2025_Article_10240.pdf"/><abstract id="Abs1"><p id="Par1">The plant kingdom is a crucial source of potential medicines, with medicinal plants playing a significant role, they have been used to treat various diseases, including cancer. Phytochemicals have emerged as promising candidates for enhancing conventional cancer treatment strategies, particularly in addressing the persistent challenges associated with such therapies. For a long time, combined therapy has been widely adopted to overcome the limitations of monotherapies. To optimize therapeutic outcomes, it is crucial to understand the mechanisms underlying the interactions between phytochemicals and conventional drugs. Based on the above, we have developed a database named InterPAD, which serves as a valuable resource to retrieve detailed information on the interactions between phytochemicals and anticancer drugs. It offers insights into their mechanisms of action and therapeutic effects, thereby facilitating a deeper understanding of how these phytochemicals can be effectively integrated into modern cancer treatment protocols. A total of 1,055 interactions involving 331 phytochemicals and 244 anticancer drugs were meticulously reviewed and manually curated from the original publications into the InterPAD database. Additionally, InterPAD curates from 680 medicinal plants, providing detailed phytochemicals-related plant information. The database also includes 619 regulatory molecules and 74 cancer types, sourced from other databases, to elucidate cancer-specific molecular mechanism and therapeutic effects. To our knowledge, InterPAD is the first comprehensive database to investigate the synergistic or antagonistic interactions of phytochemicals with drugs across various cancer types. It uniquely highlights the biological effects of phytochemicals-based anticancer interactions through the framework of &#8220;multiple-regulatory molecules and multiple-signaling pathways&#8221;, providing insights into their molecular mechanisms. This resource serves as a valuable tool for advancing research and improving cancer treatment strategies. InterPAD is accessible at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://bddg.hznu.edu.cn/interpad/">https://bddg.hznu.edu.cn/interpad/</ext-link>.</p></abstract><kwd-group xml:lang="en"><title>Keywords</title><kwd>Phytochemical</kwd><kwd>Anticancer drug</kwd><kwd>Drug interaction</kwd><kwd>Mechanisms of action</kwd><kwd>Medicinal plant</kwd><kwd>Therapeutic effect</kwd></kwd-group><kwd-group kwd-group-type="npg-subject"><title>Subject terms</title><kwd>Databases</kwd><kwd>Cancer therapy</kwd><kwd>Pharmacodynamics</kwd><kwd>Natural products</kwd><kwd>Drug delivery</kwd><kwd>Cell biology</kwd></kwd-group><funding-group><award-group><funding-source><institution-wrap><institution-id institution-id-type="FundRef">https://doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82104207</award-id><principal-award-recipient><name name-style="western"><surname>Sun</surname><given-names>Xueni</given-names></name></principal-award-recipient></award-group></funding-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>issue-copyright-statement</meta-name><meta-value>&#169; Springer Nature Limited 2025</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec id="Sec1"><title>Introduction</title><p id="Par2">In recent decades, significant advances in recognizing the molecular mechanisms of cancer biology have facilitated the discovery of numerous anticancer drugs, positioning chemotherapy as a primary modality in conventional cancer therapy<sup><xref ref-type="bibr" rid="CR1">1</xref></sup>. Anticancer drugs are widely used in clinical practice. However, monotherapy still faces various challenges, such as limited therapeutic effect<sup><xref ref-type="bibr" rid="CR2">2</xref></sup> adverse drug reaction<sup><xref ref-type="bibr" rid="CR3">3</xref></sup> and acquired drug resistance<sup><xref ref-type="bibr" rid="CR4">4</xref></sup>. Therefore, combination therapy is regarded as a promising strategy<sup><xref ref-type="bibr" rid="CR5">5</xref>&#8211;<xref ref-type="bibr" rid="CR8">8</xref></sup>. For example, cisplatin and pemetrexed are used for non-squamous cell lung cancer (NSCLC)<sup><xref ref-type="bibr" rid="CR9">9</xref></sup> 5-fluorouracil, leucovorin, and oxaliplatin are used for first-line treatment of colorectal cancer, whereas 5-fluorouracil, leucovorin, and irinotecan are used for second-line treatment of colorectal cancer<sup><xref ref-type="bibr" rid="CR10">10</xref></sup>. Drug-drug interaction (DDI) occurs when the administration of two or more drugs, either simultaneously or sequentially, leads to a significant alteration in the effect of one or more of the drugs involved<sup><xref ref-type="bibr" rid="CR11">11</xref></sup>. Conversely, adverse DDIs can undermine treatment efficacy in two primary ways: (1) by reducing drug efficacy through pharmacokinetic interference, such as enzyme induction that lowers active drug concentrations<sup><xref ref-type="bibr" rid="CR12">12</xref></sup> or (2) by increasing toxicity via pharmacodynamic synergism, exemplified by QT prolongation when used concurrently with CYP3A4 inhibitors<sup><xref ref-type="bibr" rid="CR13">13</xref></sup>. These interactions can precipitate clinically significant adverse events that undermine treatment efficacy<sup><xref ref-type="bibr" rid="CR14">14</xref></sup>.Notably, phytochemicals have garnered significant attention as potential interventions for both the prevention and treatment of a wide range of diseases<sup><xref ref-type="bibr" rid="CR15">15</xref></sup>. phytochemicals are secondary metabolites with various chemical structures and functions that are naturally found in plants including fruits, vegetables, seeds, nuts, whole grains and herbs<sup><xref ref-type="bibr" rid="CR16">16</xref>,<xref ref-type="bibr" rid="CR17">17</xref></sup> which are beneficial to human health<sup><xref ref-type="bibr" rid="CR18">18</xref>,<xref ref-type="bibr" rid="CR19">19</xref></sup>. Additionally, they also exist in diverse parts of plants such as stems, roots, rhizomes, leaves, seeds, flowers or fruits.</p><p id="Par3">The theory of Cold/Hot natures is a foundational concept in Traditional Chinese Medicine (TCM), a comprehensive medical system rooted in ancient Chinese philosophical principles, including Yin-Yang theory and the Five Elements framework<sup><xref ref-type="bibr" rid="CR20">20</xref></sup>. Characterized by a holistic worldview and syndrome differentiation<sup><xref ref-type="bibr" rid="CR21">21</xref></sup> TCM employs medicinal plants as one of its primary therapeutic modalities. The &#8220;Shennong Bencao Jing&#8221; is an ancient Chinese book on medicinal plants, explicitly describes the concept of the Four Natures (cold, hot, warm, cool)<sup><xref ref-type="bibr" rid="CR22">22</xref></sup>. Clinically, this theory dictates using cold-natured medicinal plants to treat Hot syndromes and hot-natured medicinal plants to address Cold syndromes<sup><xref ref-type="bibr" rid="CR23">23</xref></sup>. Hot syndromes are marked by symptoms such as thirst with a preference for cold drinks, red face and eyes, short and red urine, constipation, red tongue, yellow and dry coating on the tongue, and rapid pulse, whereas Cold syndromes typically manifest as fear of cold with a preference for warm drinks, pale face, long and white urine, loose stools, pale tongue, white and moist coating on the tongue, and slow pulse<sup><xref ref-type="bibr" rid="CR24">24</xref>,<xref ref-type="bibr" rid="CR25">25</xref></sup>. Notably, many anticancer drugs exhibit adverse reactions that align with TCM&#8217;s Cold/Hot categorization. For example, EGFR tyrosine kinase inhibitors (EGFR-TKIs) used in NSCLC frequently cause side effects like erythematous acneiform rash, thirst, dry tongue, and yellow tongue coating&#8212;symptoms consistent with &#8220;Hot&#8221; nature in TCM pharmacology<sup><xref ref-type="bibr" rid="CR26">26</xref></sup>. Conversely, oxaliplatin, a colorectal cancer drug associated with peripheral neuropathy characterized by limb coldness and neurogenic pain, is analogous to &#8220;Cold&#8221; nature<sup><xref ref-type="bibr" rid="CR27">27</xref></sup>. Intriguingly, network nodes implicated in Cold/Hot syndrome pathogenesis may also correlate with tumor initiation and progression<sup><xref ref-type="bibr" rid="CR28">28</xref>,<xref ref-type="bibr" rid="CR29">29</xref></sup>. Thus, classifying anticancer drugs into Cold/Hot categories based on their side effects and therapeutic profiles, and integrating the TCM theory of cold and hot, emphasizes the framework&#8217;s potential to create individualized cancer treatment strategies and drug discovery<sup><xref ref-type="bibr" rid="CR30">30</xref></sup>.</p><p id="Par4">Medicinal plants are a rich source of phytochemicals, which have been shown to play a significant role in treating human diseases<sup><xref ref-type="bibr" rid="CR31">31</xref>&#8211;<xref ref-type="bibr" rid="CR33">33</xref></sup>. A prominent example is artemisinin, which is extracted from the medicinal plant <italic toggle="yes">Artemisia annua</italic> and serves as a first-line drug for uncomplicated malaria. Interestingly, some researchers have reported that artemisinin also possesses anticancer activity and can enhance anticancer efficacy when used in combination with other anticancer drugs<sup><xref ref-type="bibr" rid="CR34">34</xref>&#8211;<xref ref-type="bibr" rid="CR36">36</xref></sup>. Currently, combinations of phytochemicals with anticancer drugs are frequently explored to improve efficacy, minimize adverse effects, and overcome drug resistance through multiple cancer-specific molecular mechanisms<sup><xref ref-type="bibr" rid="CR37">37</xref>&#8211;<xref ref-type="bibr" rid="CR39">39</xref></sup>. Successful drug-phytochemical combinations can aid researchers and clinicians in identifying beneficial phytochemical-based therapies for cancer patients<sup><xref ref-type="bibr" rid="CR40">40</xref>,<xref ref-type="bibr" rid="CR41">41</xref></sup>. However, some phytochemicals may have antagonistic effects on drugs<sup><xref ref-type="bibr" rid="CR42">42</xref>&#8211;<xref ref-type="bibr" rid="CR44">44</xref></sup> which means it is equally important to identify ineffective or harmful drug combinations in order to help researchers and clinicians avoid these detrimental drug-phytochemical combinations. Consequently, the strategy of exploring interactions between phytochemicals and anticancer drugs is being regarded as a framework in drug discovery.</p><p id="Par5">So far, numerous valuable databases have been developed to provide information related to phytochemicals, attracting significant interest from research communities. As outlined in Table&#160;<xref rid="Tab1" ref-type="table">1</xref>, some of these databases, such as HERB<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> SymMap<sup><xref ref-type="bibr" rid="CR46">46</xref></sup> HIT 2.0<sup><xref ref-type="bibr" rid="CR47">47</xref></sup> , ETCM 2.0<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> , TCMBank<sup><xref ref-type="bibr" rid="CR49">49</xref></sup> NPcVar<sup><xref ref-type="bibr" rid="CR50">50</xref></sup> focus on global phytochemicals data. Others, including NP-MRD<sup><xref ref-type="bibr" rid="CR51">51</xref></sup> SuperNatural 3.0<sup><xref ref-type="bibr" rid="CR52">52</xref></sup> , TCMID 2.0<sup><xref ref-type="bibr" rid="CR53">53</xref></sup> , COCONUT<sup><xref ref-type="bibr" rid="CR54">54</xref></sup> StreptomeDB 3.0<sup><xref ref-type="bibr" rid="CR55">55</xref></sup> , OrthoDB v9.1<sup><xref ref-type="bibr" rid="CR56">56</xref></sup> , NPAtlas 2.0<sup><xref ref-type="bibr" rid="CR57">57</xref></sup> , emphasize the structural characteristics and species classification of phytochemicals. However, these platforms generally lack pharmacological data on the interactions between phytochemicals and drugs for cancer treatment. Although certain databases, such as DDInter<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> NPCDR<sup><xref ref-type="bibr" rid="CR59">59</xref></sup> DDID<sup><xref ref-type="bibr" rid="CR60">60</xref></sup> DrugBank<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> have partially addressed DDIs, they fall short in detailing regulatory molecules and therapeutic effects of phytochemicals and drugs interactions, especially in the context of cancer-specific molecular processes. This gap hinders systematic guidance for combination therapy. Currently, no existing database offers a platform that integrates pharmacological and herbal information on the interaction effects of phytochemicals and drugs in cancer treatment. Therefore, there is an urgent need for a DDI database that encompasses a wide range of phytochemicals and drugs specifically tailored for cancer therapy.</p><p id="Par6">
<table-wrap id="Tab1" position="float" orientation="portrait"><label>Table 1</label><caption><p>A range of databases available for providing information on phytochemicals or their interactions. The first database is the newly constructed one from this work, followed by other databases classified in alphabetic order.</p></caption><table frame="hsides" rules="groups"><thead><tr><th align="left" colspan="1" rowspan="1">Database</th><th align="left" colspan="1" rowspan="1">Coverage number</th><th align="left" colspan="1" rowspan="1">Phytochemical-anticancer drug interactions</th><th align="left" colspan="1" rowspan="1">Phytochemicals</th><th align="left" colspan="1" rowspan="1">Phytochemicals related medicinal plants</th><th align="left" colspan="1" rowspan="1">Disease indication</th><th align="left" colspan="1" rowspan="1">Molecular regulation</th><th align="left" colspan="1" rowspan="1">The synergism or antagonism of phytochemicals and anticancer drugs</th><th align="left" colspan="1" rowspan="1">Classification of anticancer drugs based on medicinal plants theory (cold, hot)</th><th align="left" colspan="1" rowspan="1">Refs.</th></tr></thead><tbody><tr><td align="left" colspan="1" rowspan="1">InterPAD</td><td align="left" colspan="1" rowspan="1">1 055</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">This work</td></tr><tr><td align="left" colspan="1" rowspan="1">COCONUT</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR54">54</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">DDInter</td><td align="left" colspan="1" rowspan="1">23 684</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR58">58</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">DDID</td><td align="left" colspan="1" rowspan="1">23 950</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR60">60</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">DrugBank 6.0</td><td align="left" colspan="1" rowspan="1">1 413 413</td><td align="left" colspan="1" rowspan="1">/</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR61">61</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">ETCM 2.0</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR48">48</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">HERB</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">HIT 2.0</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR47">47</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">NPAtlas 2.0</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR57">57</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">NPcVar</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR50">50</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">NPCDR</td><td align="left" colspan="1" rowspan="1">1 172</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR59">59</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">NP-MRD</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR51">51</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">OrthoDB v9.1</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR56">56</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">StreptomeDB 3.0</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR55">55</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">SuperNatural 3.0</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR52">52</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">SymMap</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">TCMBank</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>
</td></tr><tr><td align="left" colspan="1" rowspan="1">TCMID 2.0</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#8730;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">&#215;</td><td align="left" colspan="1" rowspan="1">
<sup><xref ref-type="bibr" rid="CR53">53</xref></sup>
</td></tr></tbody></table><table-wrap-foot><p>The inclusion and exclusion of certain types of data are indicated by &#8220;&#8730;&#8221; and &#8220;&#215;&#8221;, respectively.</p><p>&#8220;/&#8220; indicates that the category includes but is not limited to the items listed.</p></table-wrap-foot></table-wrap>
</p><p id="Par7">Herein, we presented InterPAD, a novel database dedicated to exploring drug-drug Interaction between Phytochemicals and Anticancer Drugs. The database provides comprehensive integrative molecular regulation data, emphasizing the synergistic effects (e.g., enhancing drug efficacy, reversing drug resistance, and decreasing drug toxicity) or antagonistic effects (e.g., reducing drug efficacy and enhancing drug toxicity) of these combinations across various cancer cell lines and model organisms (Fig.&#160;<xref rid="Fig1" ref-type="fig">1</xref>). Synergism refers to the interaction of two or more drugs whose combined therapeutic effect exceeds the sum of their individual effects. Antagonism refers to the interaction between two or more drugs that mutually inhibit each other, resulting in diminished or nullified therapeutic effects. Subsequently, the biological phenomena (e.g., apoptosis, cell cycle arrest, autophagy, ) associated with each interaction were summarized. The underlying molecular regulations, including expression, phosphorylation, cleavage, and activity alterations, were thoroughly analyzed. Additionally, the medicinal plant theory (e.g., cold, hot) was considered to enhance drug efficacy and reduce drug toxicity. Furthermore, cross-links to other databases such as UniProt<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> TTD<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> Pfam<sup><xref ref-type="bibr" rid="CR64">64</xref></sup> KEGG<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> NCBI Gene<sup><xref ref-type="bibr" rid="CR66">66</xref></sup> Cellosaurus<sup><xref ref-type="bibr" rid="CR67">67</xref></sup> TCDB<sup><xref ref-type="bibr" rid="CR68">68</xref></sup> ChEMBL<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> DDInter<sup><xref ref-type="bibr" rid="CR58">58</xref></sup> DrugBank<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> HERB<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> PubChem<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> and others, were established to provide more detailed information. InterPAD delineates the connections of synergistic and antagonistic effects in cancer therapy, offering valuable insights for researchers in clinical oncology, network pharmacology, medical biochemistry, medicinal chemistry, drug design and related fields. InterPAD is free and open to all users without a login requirement at: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://bddg.hznu.edu.cn/interpad/">https://bddg.hznu.edu.cn/interpad/</ext-link>.</p><p id="Par8">
<fig id="Fig1" position="float" orientation="portrait"><label>Fig. 1</label><caption><p>The creative contents and characteristics of InterPAD are distinguished by its comprehensive coverage of phytochemicals and their interactions with anticancer drugs. Workflow and functional construction of InterPAD.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1016" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig1_HTML.jpg"/></fig>
</p></sec><sec id="Sec50"><title>Methods</title><sec id="Sec51"><title>Data collection and curation</title><p id="Par11">The InterPAD database was systematically collected data on interactions between phytochemicals and drugs through a structured process. Initially, a comprehensive collection of phytochemicals was compiled from well-established natural product databases such as MedChemExpress, HERB<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> ETCM v2.0<sup><xref ref-type="bibr" rid="CR48">48</xref></sup> and TCMBank<sup><xref ref-type="bibr" rid="CR49">49</xref></sup>. Subsequently, an extensive literature review of these 21,700 phytochemicals was conducted via PubMed over the past 20 years, employing a series of keyword combinations, such as &#8220;phytochemical name + anticancer drug&#8221;, &#8220;phytochemical name + anticancer drug + synergy&#8221; and &#8220;phytochemical name + drug name + antagonism&#8221;. This review yielded over 20,000 articles, from which only researches and clinical trials were retained. After rigorous screening, 983 interactions involving 331 phytochemicals and 244 anticancer drugs were included. To further expand the coverage of interactions in InterPAD, the 983 interactions were rigorously searched through the ClinicalTrials website, identifying 72 interactions with registered clinical trials. Ultimately thorough screening, a total of 1,020 articles were retained, 1,055 interactions&#8212;comprising 331 phytochemical entities and 244 anticancer drugs&#8212;were incorporated into the analysis. To ensure data accuracy, 9 PhD students participated in the entire process of information retrieval and manual data curation. Working in groups of three, any discrepancies among reviewers were resolved through discussion, with consultation of a third reviewer if necessary. All results underwent a tripartite cross-validation by three independent groups, with consensus discussions held for any divergent results.</p><p id="Par12">Moreover, the InterPAD database provides comprehensive information on both phytochemicals and anticancer drugs, encompassing details such as name, indications, clinical status, molecular weight, synonyms, formula, canonical SMILES, InChI, InChIKey, CAS, drug type, ChEMBL ID, ChEBI ID, TTD ID, Herb ID, KEGG ID and Toxicity. This data is meticulously compiled from reputable sources, including IUPHAR/BPS<sup><xref ref-type="bibr" rid="CR71">71</xref></sup> , PubChem<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> ChEMBL<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> TTD<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> HERB<sup><xref ref-type="bibr" rid="CR45">45</xref></sup>. Moreover, the database offers 2D and 3D structural representations of these compounds, which are accessible online and can be downloaded in SDF file format. Of particular note is the database&#8217;s focus on herbs containing phytochemicals, providing insights into their classification, four natures (cold, hot, warm and cool), habitat, medicinal part, meridian tropism (Medicinal plants act on specific sites or pathways within the human body)<sup><xref ref-type="bibr" rid="CR72">72</xref></sup> and five tastes (sour, bitter, sweet, pungent and salty).</p></sec><sec id="Sec53"><title>Collection of phytochemicals and drugs interactions-centered regulation information</title><p id="Par14">In the analysis of 1,055 interactions of phytochemicals and drugs for cancer therapy, interactions were categorized into two primary effects: synergism and antagonism. Synergistic effects involved enhancing drug efficacy, reversing drug resistance, and decreasing drug toxicity, whereas antagonistic effects entailed reducing drug efficacy and enhancing drug toxicity. These interactions were meticulously mapped to cancer-specific molecular mechanisms, with a comprehensive list of clinical or experimental validations provided for the therapeutic effects. Our analysis involved a thorough review of the scientific literature, focusing on experiments designed to validate potential therapeutic targets both in vitro and in vivo. We meticulously examined these studies, paying particular attention to changes in downstream signaling pathways, to evaluate the effectiveness of mechanisms of action. The data were manually curated to include regulatory molecules, biological phenomenon, mechanisms, cell lines, and in vivo models. Moreover, the molecules in InterPAD were annotated with essential information, including Gene Name, synonyms, sequence, pathway map, UniProt ID, Gene ID, T.C. Number, KEGG ID, TTD ID, and Pfam, sourced from databases such as UniProt<sup><xref ref-type="bibr" rid="CR62">62</xref></sup> KEGG<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> TTD<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> and Pfam<sup><xref ref-type="bibr" rid="CR64">64</xref></sup>. Additionally, by analyzing the theory of cold and hot, and correlating therapeutic effects with adverse reactions. We established classification criteria by mapping anticancer drug adverse reactions to TCM&#8217;s Cold/Hot syndrome diagnostics, using the ADReCs database as the primary data source<sup><xref ref-type="bibr" rid="CR73">73</xref></sup>. In addition, modern pharmacological research and clinical practice have provided valuable results<sup><xref ref-type="bibr" rid="CR26">26</xref>,<xref ref-type="bibr" rid="CR27">27</xref>,<xref ref-type="bibr" rid="CR74">74</xref></sup>. Furthermore, we used the authoritative book &#8220;Traditional Chinese Medicine Oncology&#8221; as a guide for classification standards. Notably, 6 professional Chinese medicine doctors specializing in the cancer treatment and 3 clinical pharmacologists independently reviewed classifications for 32 anticancer drugs. When there is a conflict of opinion, a third party will participate in the annotation. The framework facilitates the selection of appropriate phytomedicines within established guidelines to enhance medication relevance.</p></sec><sec id="Sec54"><title>InterPAD data standardization, access, and customized retrieval</title><p id="Par16">To enhance user access and facilitate the analysis of InterPAD data, the collected original data underwent a systematic cleaning and standardization process. This process comprised several key steps: (i) disease terms were standardized according to the latest version of the International Classification of Disease (ICD-11) issued by the World Health Organization (WHO)<sup><xref ref-type="bibr" rid="CR75">75</xref></sup>. ICD-11 is widely recognized and used globally, which facilitates the comparison and integration of data across different studies and regions. Its detailed and comprehensive framework encompasses both common and rare diseases. Crucially, ICD-11 offers specific diagnostic codes, enabling precise classification essential for accurate data analysis and efficient retrieval within our system. Furthermore, the adoption of ICD-11 promotes robust data standardization by enforcing consistent terminology across all database entries. Finally, utilizing a globally accepted classification system like ICD-11 enhances InterPAD&#8217;s interoperability with other health information systems and research databases, thereby enabling broader collaborative research endeavors. (ii) the structures of phytochemicals and drugs were converted into canonical SDF format, encompassing both 2D and 3D representations; and (iii) all entities within the InterPAD database, including phytochemicals, anticancer drugs, species, genes, pathways, disease indications, and cell lines, were cross-referenced with reputable databases, such as CAS Registry Number<sup><xref ref-type="bibr" rid="CR76">76</xref></sup> ClinicalTrial.gov<sup><xref ref-type="bibr" rid="CR77">77</xref></sup> Drugs@FDA<sup><xref ref-type="bibr" rid="CR78">78</xref></sup> DrugBank<sup><xref ref-type="bibr" rid="CR61">61</xref></sup> ChEBI<sup><xref ref-type="bibr" rid="CR69">69</xref></sup> InChl<sup><xref ref-type="bibr" rid="CR79">79</xref></sup> KEGG<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> NCBI Gene-Taxonomy<sup><xref ref-type="bibr" rid="CR80">80</xref>,<xref ref-type="bibr" rid="CR81">81</xref></sup> PubChem<sup><xref ref-type="bibr" rid="CR70">70</xref></sup> TTD<sup><xref ref-type="bibr" rid="CR63">63</xref></sup> and UniProt<sup><xref ref-type="bibr" rid="CR62">62</xref></sup>. This cross-referencing offers several key advantages for data management. First, it bolsters data accuracy by verifying information against authoritative sources, ensuring consistency and minimizing errors. Second, it enriches the overall completeness of the database by integrating supplementary details drawn from multiple, disparate sources. Finally, cross-referencing enhances interoperability by aligning our data with established standards and formats employed by other databases. The interface includes a quick search tool, enabling users to search the entire InterPAD text section for phytochemicals and anticancer drugs data via the main search box and drop-down menu.</p></sec></sec><sec id="Sec2"><title>Results</title><p id="Par17">InterPAD consists of five data parts, including phytochemicals, anticancer drugs, drug interactions, cancer types and regulatory molecules. Each interaction is verified by corresponding references.</p><sec id="Sec55"><title>Data contents in InterPAD</title><p id="Par19">InterPAD is an extensive database designed to enhance our understanding of interactions between phytochemicals and anticancer drugs. The final database documented 1,055 interactions, wherein 331 phytochemicals interact with 244 anticancer drugs. Additionally, InterPAD curates from 680 medicinal plants, providing detailed phytochemicals-related plant information. The database also includes 619 regulatory molecules and 74 cancer types to elucidate cancer-specific molecular mechanism and therapeutic effects. It is worth mentioning that we also provided the systematic data on the interactions of phytochemicals and anticancer drugs and their molecular mechanisms that were collected from reference retrieval and database mining. InterPAD introduces two significant advancements over previous phytochemical-based interaction databases. Firstly, it offers extensive information on drug interactions involving phytochemicals and anticancer drugs, detailing their clinically or experimentally validated synergistic and antagonistic effects. Secondly, it integrates medicinal plants theory and cancer-specific molecular mechanisms to demonstrate the biological effects of phytochemicals-based anticancer interactions. Consequently, the InterPAD database serves as a valuable resource for understanding the relevance of phytochemicals, anticancer drugs, their interactions, and therapeutic effects, thereby aiding in the discovery of beneficial phytochemicals-related and the avoidance of harmful ones.</p></sec><sec id="Sec56"><title>Phytochemical-related anticancer drug combinations and their therapeutic effects</title><p id="Par21">The limitations of conventional anticancer drugs, such as limited efficacy, adverse drug reactions, and acquired resistance, have been well-documented. In contrast, phytochemicals present distinct advantages, including multi-pharmacological regulation<sup><xref ref-type="bibr" rid="CR82">82</xref>,<xref ref-type="bibr" rid="CR83">83</xref></sup> low toxicity<sup><xref ref-type="bibr" rid="CR84">84</xref>,<xref ref-type="bibr" rid="CR85">85</xref></sup> and good tolerance<sup><xref ref-type="bibr" rid="CR86">86</xref>&#8211;<xref ref-type="bibr" rid="CR89">89</xref></sup> which help mitigate some of the drawbacks associated with conventional anticancer drugs. The effectiveness and safety of a drug are largely contingent upon its multi-dimensional interactions with various molecular types within its combination<sup><xref ref-type="bibr" rid="CR90">90</xref>&#8211;<xref ref-type="bibr" rid="CR92">92</xref></sup>. A comprehensive and integrative understanding of these interactions is crucial for determining whether phytochemical-drug combinations exhibit synergistic or antagonistic effects. These concomitant drugs have been categorized according to five interaction effects of phytochemicals: (i) drugs whose efficacy can be enhanced by the phytochemicals, (ii) drugs whose resistance can be reversed by the phytochemicals, (iii) drugs whose toxicity can be decreased by the phytochemicals, (iv) drugs whose efficacy can be decreased by the phytochemicals, (v) drugs whose toxicity can be increased by the phytochemicals. Among these interactions, enhancing drug efficacy, reversing drug resistance, and decreasing drug toxicity are considered as synergistic effects, whereas reducing drug efficacy and enhancing drug toxicity are considered as antagonistic effects.</p><p id="Par22">In the InterPAD database, the interactions between phytochemicals and drugs are systematically visualized and analyzed. The database reveals that 307 phytochemicals enhanced the efficacy of 198 anticancer drugs across 760 interactions, benefitting the treatment of 66 cancer types, 72 phytochemicals have been identified to reverse drug resistance in 28 anticancer drugs through 93 interactions, addressing 19 cancer types. Furthermore, 65 phytochemicals were noted for their ability to reduce the toxicity of 34 anticancer drugs in 82 interactions, impacting 29 cancer types. Furthermore, the cold and hot theory in TCM is valuable framework for understanding the therapeutic application of medicinal plants. It helps evaluate clinical symptoms and potential adverse reactions of anticancer drugs, guiding in the selection of medicinal plants to mitigate these symptoms. This information is accessible in the &#8220;Search for Interaction by Effect&#8221; section of Drug Interaction in InterPAD.</p><p id="Par23">The analysis identified that 3 phytochemicals reduced the efficacy of 41 anticancer drugs across 41 interactions, while 7 phytochemicals were linked to increased toxicity of 6 anticancer drugs across 7 interactions. Figure&#160;<xref rid="Fig2" ref-type="fig">2</xref> illustrates the therapeutic efficacy of each phytochemical-drug interaction, and the InterPAD database provides detailed clinically or experimentally observed treatment effects. The identification of successful drug combinations can guide researchers and doctors in selecting beneficial phytochemicals-based therapies for cancer patients. Conversely, recognizing ineffective drug combinations can help avoid detrimental interactions. In summary, InterPAD offers an extensive collection phytochemical drug interaction and represents the first comprehensive knowledge base to elucidate both synergistic and antagonistic effects of these interactions in cancer therapy.</p><p id="Par24">
<fig id="Fig2" position="float" orientation="portrait"><label>Fig. 2</label><caption><p>A typical InterPAD webpage for drug interaction. The phytochemicals were reported to produce synergistic effects by enhancing drug efficacy, reversing drug resistance, and decreasing drug toxicity, or antagonistic effects by reducing drug efficacy and enhancing drug toxicity. The therapeutic effects of various interaction between phytochemicals and anticancer drugs are then displayed. Using &#8220;Artesunate, Fluorouracil&#8221; as an example, based on the theory of cold and hot, this theory was fully applied to anticancer drugs, and appropriate medicinal plants were selected within the guidelines to enhance the efficacy of this interaction and decrease the toxicity of fluorouracil.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1210" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig2_HTML.jpg"/></fig>
</p></sec><sec id="Sec57"><title>The interaction pattern of the collected phytochemicals with diverse medicinal plants</title><p id="Par26">In recent years, the value of medicinal plants has been increasingly recognized, serving as a vital resource for modern drug development<sup><xref ref-type="bibr" rid="CR93">93</xref>&#8211;<xref ref-type="bibr" rid="CR95">95</xref></sup>. For instance, the combination of active ingredients-Honokiol, magnolol, baicalin-from Huangqin Houpo decoction exhibits synergistic anticancer effects in both in vivo and in vitro models of colorectal cancer<sup><xref ref-type="bibr" rid="CR96">96</xref></sup>. Additionally, paclitaxel, derived from the mature Pacific yew tree (<italic toggle="yes">Taxus brevifolia</italic>), possesses broad-spectrum anticancer effects, including breast<sup><xref ref-type="bibr" rid="CR97">97</xref>,<xref ref-type="bibr" rid="CR98">98</xref></sup> ovarian<sup><xref ref-type="bibr" rid="CR99">99</xref></sup> and gastric cancer<sup><xref ref-type="bibr" rid="CR100">100</xref></sup>. Notably, recent advances in synthetic biology have for the first time revealed the enzymes that catalyze the final two modifications of paclitaxel biosynthesis, that is, C2&#8242;&#945; hydroxylation and 3&#8242;-N benzoylation<sup><xref ref-type="bibr" rid="CR101">101</xref></sup>. This provides new insights into the sustainable production of complex phytochemicals, thereby overcoming supply constraints. As a result, medicinal plants provide a foundation for exploring new research directions from a modern scientific perspective. The InterPAD database has cataloged 680 phytochemicals-related medicinal plants, providing detailed medicinal plant information on its webpage. This information includes the plant&#8217;s name, classification (kingdom, phylum, class, order, family, genus, species), habitat, four natures, five tastes, medicinal part, and meridian tropism. For instance, Curcumin, a prominent phytochemical, can be sourced from several medicinal plants, such as <italic toggle="yes">Curcuma longa</italic>, <italic toggle="yes">Curcuma kwangsiensis</italic> and <italic toggle="yes">Alpinia officinarum</italic>, as illustrated in Fig.&#160;<xref rid="Fig3" ref-type="fig">3</xref>, <italic toggle="yes">Curcuma longa</italic>, in particular, is classified as having a warm nature, with its tuberoid part being utilized. It is cultivated in regions such as Sichuan, Fujian, Guangdong, Zhejiang, and Jiangxi in China. The plant is characterized by a pungent and bitter, and is associated with the spleen and liver meridians. Additionally, the systematic classification of <italic toggle="yes">Curcuma longa</italic> into kingdom, phylum, class, order, family, genus and species was comprehensively summarized. The data were sourced from the Chinese Pharmacopoeia (2020 Edition), HERB<sup><xref ref-type="bibr" rid="CR45">45</xref></sup> ETCM v2.0<sup>48</sup> and SymMap<sup><xref ref-type="bibr" rid="CR46">46</xref></sup>. In traditional medicine practice, the nature of medicinal plants is highlighted in color after their name. Diverse medicinal plants with similar properties can be used to treat diseases exhibiting opposite properties. Thus, understanding the cold-hot-warm-cool nature of medicinal plants is crucial for appreciating their synergistic therapeutic effects alongside anticancer drug.</p><p id="Par27">
<fig id="Fig3" position="float" orientation="portrait"><label>Fig. 3</label><caption><p>The interaction diagram of the collected phytochemicals with diverse medicinal plants. Taking &#8220;Curcumin&#8221; as an example, its related medicinal plants information is detailedly presented in the webpage, including medicinal plant name, four natures, use part, habitat, flavor, meridian tropism, and classification (kingdom, phylum, class, order, family, genus, species).</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1287" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig3_HTML.jpg"/></fig>
</p></sec><sec id="Sec58"><title>Description and visualization of the drug&#8217;s interaction pattern</title><p id="Par29">InterPAD provides users the ability to explore specific cancer types and their associated phytochemical-drug interactions through interactive visual diagrams. For instance, Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>A illustrates the various phytochemicals and drugs associated with &#8220;Lung cancer&#8221; through an interactive diagram. By hovering over the diagram and selecting &#8220;Click to details&#8221;. Users can access more in-depth information about each interaction. Additionally, users can select a combination of drugs to discover the corresponding disease type, as demonstrated in Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>B. The platform also enables users to search for specific phytochemicals within the drug interactions interface, presenting all associated cancer types and drugs in the interaction graph. For example, Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>C showcases the different cancer types and anticancer drugs linked to &#8220;Curcumin&#8221; in an interactive format. Similarly, as illustrated in Fig.&#160;<xref rid="Fig4" ref-type="fig">4</xref>D with &#8220;Fluorouracil&#8221; displays the diverse cancer types and phytochemicals correlated with &#8220;Fluorouracil&#8221;. This functionality enables users to explore specific anticancer drugs and uncover all related cancer types and phytochemicals, enhancing the platform&#8217;s utility for research and clinical applications. Furthermore, InterPAD provides comprehensive information on the clinical status of phytochemicals, drugs, and their combinations, as sourced from ClinicalTrials.gov<sup><xref ref-type="bibr" rid="CR77">77</xref></sup>. Each interaction is meticulously annotated and can be accessed interactively online, ensuring thorough exploration and understanding of the data.</p><p id="Par30">
<fig id="Fig4" position="float" orientation="portrait"><label>Fig. 4</label><caption><p>A typical InterPAD webpage for interactive diagram. (<bold>A</bold>) Using &#8220;lung cancer&#8221; as an example, the diagram displays the various phytochemicals and drugs associated with it, along with interaction effects and clinical status for the treatment of lung cancer. (<bold>B</bold>) Using &#8220;Epigallocatechin gallate, Irinotecan&#8221; as an example, the diagram displays the various diseases associated with this combination. (<bold>C</bold>) Taking &#8220;Curcumin&#8221; as an example, the interactive diagram shows the various cancer types and anticancer drugs associated with it. (<bold>D</bold>) Taking &#8220;Fluorouracil&#8221; as an example, the interactive diagram presents the varied cancer types and phytochemicals interrelated with it.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1330" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig4_HTML.jpg"/></fig>
</p></sec><sec id="Sec59"><title>The biological effects of phytochemical-related anticancer drug interactions and potential molecular mechanisms</title><p id="Par32">The InterPAD database catalogues 619 molecules, including proteins and RNAs, along with 613 signaling pathways influenced by interactions between phytochemicals and anticancer drugs. Each original publication was meticulously analyzed to establish the correlation between these interactions and cancer-related molecular regulations. As shown in Fig.&#160;<xref rid="Fig5" ref-type="fig">5</xref>, InterPAD offers detailed curation of the biological phenomena resulting from each combination, such as the induction of mitochondria-mediated apoptosis, cell cycle arrest, glycolysis, reactive oxygen species (ROS) generation, endoplasmic reticulum stress, immunomodulatory effects, and the inhibition of epithelial-mesenchymal transition (EMT). Beyond documenting these biological phenomena, InterPAD also elucidates the underlying molecular mechanisms, highlighting specific molecular modifications like cleavage, activity changes, phosphorylation, and acetylation. Consequently, the molecular regulation and biological activity data provided by InterPAD are essential for understanding the mechanisms of phytochemicals in combination with specific anticancer drugs. This understanding is critical for improving drug efficacy, overcoming drug resistance, minimizing toxicity, and preventing both reduced effectiveness and increased adverse effects of drugs.</p><p id="Par33">
<fig id="Fig5" position="float" orientation="portrait"><label>Fig. 5</label><caption><p>Detailed interactions of phytochemicals and drugs are categorized based on their therapeutic effects. Mechanisms of molecular regulation, signaling pathways, and biological phenomenon are comprehensively described. These interaction data are associated with diverse cell lines and model organisms, and the resultant changes in mechanism of action are detailed. An extended explanation of each regulated molecule can be accessed by clicking on the &#8220;gene name&#8221;.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1347" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig5_HTML.jpg"/></fig>
</p><p id="Par34">InterPAD offers comprehensive data on the therapeutic effects of each combination by systematically presenting molecular mechanisms, biological activity information, and experimental details on the clinical or experimental validation page. The database includes 479 cell lines from various disease and species origins, alongside four model organisms, such as zebrafish, mice, rats and rabbits, which are utilized to characterize the regulatory information for each interaction. Disease models, both in vitro and in vivo, were categorized base on the disease names from the original publications. Moreover, the database documents diverse experimental techniques used to access molecular regulation and biological activity, including western blotting, quantitative polymerase chain reaction (qPCR), short hairpin RNA (shRNA), small interfering RNA (siRNA), flow cytometry assays. These findings are manually linked to the KEGG database<sup><xref ref-type="bibr" rid="CR65">65</xref></sup> with corresponding regulatory molecules highlighted on their pathway maps. Users can access extended information on each regulatory molecule by clicking on its name, as demonstrated in Fig.&#160;<xref rid="Fig6" ref-type="fig">6</xref>. Finally, by clicking on the &#8220;References&#8221; icon, users can navigate to the bottom bar of the screen to explore the cited literature further.</p><p id="Par35">
<fig id="Fig6" position="float" orientation="portrait"><label>Fig. 6</label><caption><p>Detailed interactions of phytochemicals and drugs are categorized based on regulated molecules. For instance, &#8220;NFE2L2&#8221; is used as an example, with its general information displayed in front part. The interaction effects of NFE2L2 on a list of interactions between phytochemicals and drugs that have been clinically or experimentally validated are collected in the lower.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1366" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig6_HTML.jpg"/></fig>
</p></sec><sec id="Sec60"><title>InterPAD case study</title><p id="Par37">The database has been thoroughly validated by researchers and clinicians, whose feedback has directly enriched and enhanced the convenience of InterPAD. The research content of InterPAD focuses on the interactions between phytochemicals and anticancer drugs, providing extensive support for relevant scientific research. Taking the interaction between curcumin and fluorouracil as a key example, the process is as follows: Firstly, on the drug interaction interface, search by drug interaction classification. Then, click on &#8220;Synergistic Effect: Decreasing Drug Toxicity&#8221; (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>A) to display all interactions related to this entry. Next, select the interaction entry for curcumin and fluorouracil to show the registered clinical trials corresponding to this interaction in the study (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>B). Subsequently, clicking on the pair name will display the basic information of curcumin and fluorouracil (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>C). Moreover, this section presents content related to the &#8220;The theory of cold and hot&#8221;, inferring the potential nature of fluorouracil based on its adverse reactions and providing potential recommendations (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>D). Finally, it details both in <italic toggle="yes">vivo</italic> and in <italic toggle="yes">vitro</italic> experimental results for this interaction (Fig.&#160;<xref rid="Fig7" ref-type="fig">7</xref>E). All blue-highlighted text is linkable to relevant websites for further information. Thus, the database can be searched directly through interaction to obtain information related to phytochemicals and anticancer drugs, providing a convenient and integrated search channel for research in this field.</p><p id="Par38">
<fig id="Fig7" position="float" orientation="portrait"><label>Fig. 7</label><caption><p>A case study of InterPAD. (<bold>A</bold>)The &#8220;Search for Interaction by Effect&#8221; interface of Drug Interaction in InterPAD. (<bold>B</bold>) Search interface for information on &#8220;Decreasing Drug Toxicity&#8221;. (<bold>C</bold>) The basic information of curcumin and fluorouracil. (<bold>D</bold>) The information of &#8220;The theory of cold and hot&#8221;. (<bold>E</bold>) The information of gene regulation and animal experiments.</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" id="d33e1418" position="float" orientation="portrait" xlink:href="41598_2025_10240_Fig7_HTML.jpg"/></fig>
</p></sec></sec><sec id="Sec65"><title>Discussions</title><p id="Par40">Nature, as a unique origin system, is abundant with medicinal plants that exhibit significant biological activities and medicinal properties, making it a crucial source for medicine plant development. The systematic exploration of drug interaction is essential for advancing phytomedicine research and development. In this study, InterPAD enables users to conduct multi-dimensional and multi-level correlation analyses among phytochemicals, medicinal plants, anticancer drugs, interactions, cancer types, and molecules. The data provided by InterPAD sheds light on the complex mechanisms underlying phytochemical-anticancer drug interactions, aligning with the &#8220;multiple-regulatory molecules and multiple-signaling pathways&#8221; model of comprehensive cancer therapy. This approach improves the synergy effects of the conventional anticancer drugs and avoids potential antagonistic effects. Importantly, we propose that the classification of anticancer drugs based on the &#8220;cold and hot&#8221; theory is a valuable approach that integrates traditional wisdom with modern scientific understanding. While further validation is needed, the existing literature provides a foundation for this classification.</p><p id="Par41">The detection of interactions between phytochemicals and anticancer drugs primarily depends on in vitro, in vivo experimental methods<sup><xref ref-type="bibr" rid="CR102">102</xref>,<xref ref-type="bibr" rid="CR103">103</xref></sup> and some clinical trials<sup><xref ref-type="bibr" rid="CR104">104</xref>,<xref ref-type="bibr" rid="CR105">105</xref></sup>. Notably, the combination therapy of epigallocatechin gallate with gefitinib has been shown to effectively activate the AMPK pathway while inhibiting the ERK/MAPK and AKT/mTOR pathways. This leads to cell cycle arrest and apoptosis, particularly in drug-resistant NSCLC cells, thereby demonstrating the synergistic effects of this combination therapy in vitro<sup><xref ref-type="bibr" rid="CR106">106</xref></sup>. Similarly, the combination of ginseng polysaccharide and &#945;PD-1 monoclonal antibody may offer a novel strategy to enhance the sensitivity of NSCLC patients to anti-PD-1 immunotherapy, demonstrating the synergistic antitumor effects of this combination therapy in <italic toggle="yes">vivo</italic><sup><xref ref-type="bibr" rid="CR8">8</xref></sup>. In addition, a phase II clinical trial suggests the safety and feasibility of combination therapy with curcumin and gemcitabine<sup><xref ref-type="bibr" rid="CR107">107</xref></sup>. Moreover, the findings of a phase I clinical trial investigating the combination of curcumin and docetaxel in patients with advanced and metastatic breast cancer indicated tolerability and feasibility<sup><xref ref-type="bibr" rid="CR108">108</xref></sup>.</p><p id="Par42">Despite the promising progress of numerous combination therapies entering clinical trials, these trials may still be put on hold or terminated due to inadequate efficacy or safety issues. It is crucial to acknowledge inherent limitations in extrapolating preclinical data on phytochemical-anticancer drug combinations to human clinical outcomes. These limitations arise from several factors: (i) While our database is grounded in robust preclinical research and some clinical evidence, the synergistic mechanisms underlying phytochemical-anticancer drug combinations remain incompletely elucidated due to the inherent complexity and uncertainty surrounding the target regulatory networks of phytochemicals, which can impede their clinical translation. Furthermore, certain phytochemicals may exhibit antagonistic interactions with anticancer drugs, thereby attenuating therapeutic efficacy. (ii) Although phytochemicals are generally recognized for their low toxicity profiles, a subset exhibits significant toxicity, restricting their clinical utility<sup><xref ref-type="bibr" rid="CR109">109</xref></sup>. (iii) Tumor heterogeneity contributes to variations in the efficacy of combined phytochemical-anticancer drug therapy across different patients, thereby increasing the complexity of clinical research. (iv) Preclinical studies often employ higher phytochemical doses and shorter treatment durations compared to clinical trials, potentially leading to an overestimation of treatment efficacy and an underestimation of long-term adverse effects, complicating the precise control of combination dosages and drug ratios. (v) Variability in planting cycles and harvesting seasons can influence phytochemical composition, leading to challenges in quality control and standardization of data across different batches of combination drugs. Despite these limitations, the combination of phytochemicals and anticancer drugs continues to hold significant therapeutic potential. To address these challenges, we propose potential solutions for researchers, including the use of organoid models to screen for interactions between phytochemicals and anticancer drugs<sup><xref ref-type="bibr" rid="CR62">62</xref>,<xref ref-type="bibr" rid="CR110">110</xref></sup> establishing a &#8220;chemical fingerprint profile&#8221; of phytochemicals using Ultra high performance liquid chromatography quadrupole time-of-flight tandem mass spectrometry (UPLC-Q-TOF-MS) to ensure batch-to-batch consistency<sup><xref ref-type="bibr" rid="CR111">111</xref>,<xref ref-type="bibr" rid="CR112">112</xref></sup> and enhancing the bioavailability and stability of phytochemicals through nanotechnology and other advanced delivery systems<sup><xref ref-type="bibr" rid="CR113">113</xref></sup>.</p><p id="Par43">Although several databases document phytochemicals and their species classification, there remains a notable absence of a comprehensive database specifically detailing phytochemical-anticancer drug interactions and their clinically or experimentally validated synergistic and antagonistic effects. To address this gap, we developed a database (InterPAD) to provide a valuable resource for understanding the relevance of phytochemicals, anticancer drugs, interactions, regulatory molecules, mechanism of action and therapeutic effects. Firstly, InterPAD encompasses extensive information on drug combinations involving phytochemicals and conventional anticancer drugs, including both synergistic and antagonistic effects validated through clinical or experimental studies, which are often neglected in basic research but are crucial in clinical practice. Secondly, InterPAD provides comprehensive details about the anticancer properties of phytochemicals and their source medicinal plants, including specific bioactivities, characteristics and traditional medicinal plant theory. Thirdly, our study represents a significant step forward by integrating insights from multiple disciplines, including pharmacology, drug design, botany, medicinal chemistry, bioinformatics, and systems biology. This interdisciplinary approach allows us to tackle the complex issue of drug interactions from multiple angles, providing a more holistic understanding than studies confined to a single discipline. For example, InterPAD facilitates users in conducting multi-level and multi-dimensional correlation analyses among medicinal plants, phytochemicals, anticancer drugs, diseases, and regulatory molecules.</p><p id="Par44">In InterPAD, we focus on the interactions between phytochemicals and anticancer drugs. As interest in phytochemicals-based interactions continues to grow, the volume of data on these interactions is anticipated to expand significantly. InterPAD bridges the gap between phytochemicals and modern pharmaceutical research, laying the groundwork for future studies on predictive models and web tools for phytochemical-drug interactions. Currently, interaction studies based on artificial intelligence (AI) are increasingly gaining attention<sup><xref ref-type="bibr" rid="CR114">114</xref>,<xref ref-type="bibr" rid="CR115">115</xref></sup>. For instance, the study on food/herb&#8211;drug interactions and hepatoprotective effect predictions based on structure&#8211;activity relationships<sup><xref ref-type="bibr" rid="CR116">116</xref></sup>. In addition, a novel deep multimodal feature fusion framework for predicting DDIs has been developed, which integrates drug molecular graphs, DDI networks, and biochemical similarity features of drugs to predict DDIs<sup><xref ref-type="bibr" rid="CR117">117</xref></sup>. However, research on the prediction of interactions between phytochemicals and anticancer drugs remains limited. Therefore, collecting data on interactions between phytochemicals and anticancer drugs provides a basis for AI algorithms to analyze, thereby enabling more effective and evidenced research strategies.</p></sec></body><back><fn-group><fn><p><bold>Publisher&#8217;s note</bold></p><p>Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></fn><fn><p>Aili Zhang and Xueni Sun contributed equally to this work.</p></fn></fn-group><notes notes-type="author-contribution"><title>Author contributions</title><p>A.Z.: Conceptualization; Investigation; Data curation; Writing &#8211; original draft; Writing &#8211; review &amp; editing. X.S.: Supervision; Writing &#8211; review &amp; editing. Q.W.: Supervision; Writing &#8211; review &amp; editing. H.J.: Data curation. L.X.: Data curation. Q.G.: Software. Z.Y.: Software. S.Z.: Software. X.S.: Supervision; Validation; Writing &#8211; review &amp; editing. All data were generated in-house, and no paper mill was used. All authors agree to be accountable for all aspects of work ensuring integrity and accuracy.</p></notes><notes notes-type="funding-information"><title>Funding</title><p>This study is supported by the National Natural Science Foundation of China (Grant No. 82104207).</p></notes><notes notes-type="data-availability"><title>Data availability</title><p>The InterPAD database can be accessed at <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://bddg.hznu.edu.cn/interpad/">https://bddg.hznu.edu.cn/interpad/</ext-link>, and the web server is compatible with Chrome, Edge, Opera, Safari and Firefox.</p></notes><notes><title>Declarations</title><notes id="FPar1" notes-type="COI-statement"><title>Competing interests</title><p id="Par46">The authors declare no competing interests.</p></notes></notes><ref-list id="Bib1"><title>References</title><ref id="CR1"><label>1.</label><citation-alternatives><element-citation id="ec-CR1" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Audisio</surname><given-names>A</given-names></name><etal/></person-group><article-title>Neoadjuvant chemotherapy for early-stage colon cancer</article-title><source>Cancer Treat. Rev.</source><year>2024</year><volume>123</volume><fpage>102676</fpage><pub-id pub-id-type="pmid">38160535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ctrv.2023.102676</pub-id></element-citation><mixed-citation id="mc-CR1" publication-type="journal">Audisio, A. et al. Neoadjuvant chemotherapy for early-stage colon cancer. <italic toggle="yes">Cancer Treat. Rev.</italic><bold>123</bold>, 102676 (2024).<pub-id pub-id-type="pmid">38160535</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ctrv.2023.102676</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR2"><label>2.</label><citation-alternatives><element-citation id="ec-CR2" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bailly</surname><given-names>C</given-names></name></person-group><article-title>Irinotecan: 25 years of cancer treatment</article-title><source>Pharmacol. Res.</source><year>2019</year><volume>148</volume><fpage>104398</fpage><pub-id pub-id-type="pmid">31415916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2019.104398</pub-id></element-citation><mixed-citation id="mc-CR2" publication-type="journal">Bailly, C. Irinotecan: 25 years of cancer treatment. <italic toggle="yes">Pharmacol. Res.</italic><bold>148</bold>, 104398 (2019).<pub-id pub-id-type="pmid">31415916</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2019.104398</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR3"><label>3.</label><citation-alternatives><element-citation id="ec-CR3" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shyam Sunder</surname><given-names>S</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>UC</given-names></name><name name-style="western"><surname>Pokharel</surname><given-names>S</given-names></name></person-group><article-title>Adverse effects of tyrosine kinase inhibitors in cancer therapy: pathophysiology, mechanisms and clinical management</article-title><source>Signal. Transduct. Target. Therapy</source><year>2023</year><volume>8</volume><fpage>262</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-023-01469-6</pub-id><pub-id pub-id-type="pmcid">PMC10326056</pub-id><pub-id pub-id-type="pmid">37414756</pub-id></element-citation><mixed-citation id="mc-CR3" publication-type="journal">Shyam Sunder, S., Sharma, U. C. &amp; Pokharel, S. Adverse effects of tyrosine kinase inhibitors in cancer therapy: Pathophysiology, mechanisms and clinical management. <italic toggle="yes">Signal. Transduct. Target. Ther.</italic><bold>8</bold>, 262 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41392-023-01469-6</pub-id><pub-id pub-id-type="pmcid">PMC10326056</pub-id><pub-id pub-id-type="pmid">37414756</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR4"><label>4.</label><citation-alternatives><element-citation id="ec-CR4" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Holohan</surname><given-names>C</given-names></name><name name-style="western"><surname>Van Schaeybroeck</surname><given-names>S</given-names></name><name name-style="western"><surname>Longley</surname><given-names>DB</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>PG</given-names></name></person-group><article-title>Cancer drug resistance: an evolving paradigm</article-title><source>Nat. Rev. Cancer</source><year>2013</year><volume>13</volume><fpage>714</fpage><lpage>726</lpage><pub-id pub-id-type="pmid">24060863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc3599</pub-id></element-citation><mixed-citation id="mc-CR4" publication-type="journal">Holohan, C., Van Schaeybroeck, S., Longley, D. B. &amp; Johnston, P. G. Cancer drug resistance: An evolving paradigm. <italic toggle="yes">Nat. Rev. Cancer</italic><bold>13</bold>, 714&#8211;726 (2013).<pub-id pub-id-type="pmid">24060863</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrc3599</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR5"><label>5.</label><citation-alternatives><element-citation id="ec-CR5" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Obenauf</surname><given-names>AC</given-names></name></person-group><article-title>Mechanism-based combination therapies for metastatic cancer</article-title><source>Sci. Transl Med.</source><year>2022</year><volume>14</volume><fpage>eadd0887</fpage><pub-id pub-id-type="pmid">35895833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.add0887</pub-id></element-citation><mixed-citation id="mc-CR5" publication-type="journal">Obenauf, A. C. Mechanism-based combination therapies for metastatic cancer. <italic toggle="yes">Sci. Transl. Med.</italic><bold>14</bold>, eadd0887 (2022).<pub-id pub-id-type="pmid">35895833</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1126/scitranslmed.add0887</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR6"><label>6.</label><citation-alternatives><element-citation id="ec-CR6" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Plana</surname><given-names>D</given-names></name><name name-style="western"><surname>Palmer</surname><given-names>AC</given-names></name><name name-style="western"><surname>Sorger</surname><given-names>PK</given-names></name></person-group><article-title>Independent drug action in combination therapy: implications for precision oncology</article-title><source>Cancer Discov</source><year>2022</year><volume>12</volume><fpage>606</fpage><lpage>624</lpage><pub-id pub-id-type="pmid">34983746</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2159-8290.CD-21-0212</pub-id><pub-id pub-id-type="pmcid">PMC8904281</pub-id></element-citation><mixed-citation id="mc-CR6" publication-type="journal">Plana, D., Palmer, A. C. &amp; Sorger, P. K. Independent drug action in combination therapy: Implications for precision oncology. <italic toggle="yes">Cancer Discov.</italic><bold>12</bold>, 606&#8211;624 (2022).<pub-id pub-id-type="pmid">34983746</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1158/2159-8290.CD-21-0212</pub-id><pub-id pub-id-type="pmcid">PMC8904281</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR7"><label>7.</label><citation-alternatives><element-citation id="ec-CR7" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Webster</surname><given-names>RM</given-names></name></person-group><article-title>Combination therapies in oncology</article-title><source>Nat. Rev. Drug Discov</source><year>2016</year><volume>15</volume><fpage>81</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">26837588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd.2016.3</pub-id></element-citation><mixed-citation id="mc-CR7" publication-type="journal">Webster, R. M. Combination therapies in oncology. <italic toggle="yes">Nat. Rev. Drug Discov.</italic><bold>15</bold>, 81&#8211;82 (2016).<pub-id pub-id-type="pmid">26837588</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/nrd.2016.3</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR8"><label>8.</label><citation-alternatives><element-citation id="ec-CR8" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy</article-title><source>Gut</source><year>2022</year><volume>71</volume><fpage>734</fpage><lpage>745</lpage><pub-id pub-id-type="pmid">34006584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2020-321031</pub-id><pub-id pub-id-type="pmcid">PMC8921579</pub-id></element-citation><mixed-citation id="mc-CR8" publication-type="journal">Huang, J. et al. Ginseng polysaccharides alter the gut microbiota and kynurenine/tryptophan ratio, potentiating the antitumour effect of antiprogrammed cell death 1/programmed cell death ligand 1 (anti-PD-1/PD-L1) immunotherapy. <italic toggle="yes">Gut</italic><bold>71</bold>, 734&#8211;745 (2022).<pub-id pub-id-type="pmid">34006584</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/gutjnl-2020-321031</pub-id><pub-id pub-id-type="pmcid">PMC8921579</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR9"><label>9.</label><citation-alternatives><element-citation id="ec-CR9" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Phase III KEYNOTE-789 study of pemetrexed and platinum with or without pembrolizumab for tyrosine kinase Inhibitor&#8211;Resistant, EGFR-Mutant, metastatic nonsquamous Non-Small cell lung Cancer</article-title><source>J. Clin. Oncol.</source><year>2024</year><volume>42</volume><fpage>4029</fpage><lpage>4039</lpage><pub-id pub-id-type="pmid">39173098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.23.02747</pub-id><pub-id pub-id-type="pmcid">PMC11608596</pub-id></element-citation><mixed-citation id="mc-CR9" publication-type="journal">Yang, J. C. et al. Phase III KEYNOTE-789 study of pemetrexed and platinum with or without pembrolizumab for tyrosine kinase Inhibitor&#8211;Resistant, EGFR-Mutant, metastatic nonsquamous Non-Small cell lung Cancer. <italic toggle="yes">J. Clin. Oncol.</italic><bold>42</bold>, 4029&#8211;4039 (2024).<pub-id pub-id-type="pmid">39173098</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.23.02747</pub-id><pub-id pub-id-type="pmcid">PMC11608596</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR10"><label>10.</label><citation-alternatives><element-citation id="ec-CR10" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fior</surname><given-names>R</given-names></name><etal/></person-group><article-title>Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts</article-title><source>Proc. Natl. Acad. Sci. U S A</source><year>2017</year><volume>114</volume><fpage>E8234</fpage><lpage>E8243</lpage><pub-id pub-id-type="pmid">28835536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1618389114</pub-id><pub-id pub-id-type="pmcid">PMC5625889</pub-id></element-citation><mixed-citation id="mc-CR10" publication-type="journal">Fior, R. et al. Single-cell functional and chemosensitive profiling of combinatorial colorectal therapy in zebrafish xenografts. <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic><bold>114</bold>, E8234&#8211;E8243 (2017).<pub-id pub-id-type="pmid">28835536</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1618389114</pub-id><pub-id pub-id-type="pmcid">PMC5625889</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR11"><label>11.</label><mixed-citation publication-type="other">Zhao, Y., Yin, J., Zhang, L., Zhang, Y. &amp; Chen, X. Drug-drug interaction prediction: Databases, web servers and computational models. <italic toggle="yes">Brief Bioinform.</italic><bold>25</bold> (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbad445</pub-id><pub-id pub-id-type="pmcid">PMC10782925</pub-id><pub-id pub-id-type="pmid">38113076</pub-id></mixed-citation></ref><ref id="CR12"><label>12.</label><citation-alternatives><element-citation id="ec-CR12" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Dilger</surname><given-names>K</given-names></name><name name-style="western"><surname>Hofmann</surname><given-names>U</given-names></name><name name-style="western"><surname>Klotz</surname><given-names>U</given-names></name></person-group><article-title>Enzyme induction in the elderly: effect of Rifampin on the pharmacokinetics and pharmacodynamics of propafenone</article-title><source>Clin. Pharmacol. Ther.</source><year>2000</year><volume>67</volume><fpage>512</fpage><lpage>520</lpage><pub-id pub-id-type="pmid">10824630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mcp.2000.106872</pub-id></element-citation><mixed-citation id="mc-CR12" publication-type="journal">Dilger, K., Hofmann, U. &amp; Klotz, U. Enzyme induction in the elderly: Effect of Rifampin on the pharmacokinetics and pharmacodynamics of propafenone. <italic toggle="yes">Clin. Pharmacol. Ther.</italic><bold>67</bold>, 512&#8211;520 (2000).<pub-id pub-id-type="pmid">10824630</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1067/mcp.2000.106872</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR13"><label>13.</label><citation-alternatives><element-citation id="ec-CR13" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>X</given-names></name><etal/></person-group><article-title>Macrolides use and the risk of sudden cardiac death</article-title><source>Expert Rev. Anti Infect. Ther.</source><year>2016</year><volume>14</volume><fpage>535</fpage><lpage>537</lpage><pub-id pub-id-type="pmid">27086751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14787210.2016.1179580</pub-id></element-citation><mixed-citation id="mc-CR13" publication-type="journal">Li, X. et al. Macrolides use and the risk of sudden cardiac death. <italic toggle="yes">Expert Rev. Anti Infect. Ther.</italic><bold>14</bold>, 535&#8211;537 (2016).<pub-id pub-id-type="pmid">27086751</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/14787210.2016.1179580</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR14"><label>14.</label><citation-alternatives><element-citation id="ec-CR14" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>NN</given-names></name><etal/></person-group><article-title>Comprehensive review of Drug-Drug interaction prediction based on machine learning: current status, challenges, and opportunities</article-title><source>J. Chem. Inf. Model.</source><year>2024</year><volume>64</volume><fpage>96</fpage><lpage>109</lpage><pub-id pub-id-type="pmid">38132638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.3c01304</pub-id></element-citation><mixed-citation id="mc-CR14" publication-type="journal">Wang, N. N. et al. Comprehensive review of drug-drug interaction prediction based on machine learning: Current status, challenges, and opportunities. <italic toggle="yes">J. Chem. Inf. Model.</italic><bold>64</bold>, 96&#8211;109 (2024).<pub-id pub-id-type="pmid">38132638</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.3c01304</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR15"><label>15.</label><citation-alternatives><element-citation id="ec-CR15" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zarifi</surname><given-names>SH</given-names></name><name name-style="western"><surname>Bagherniya</surname><given-names>M</given-names></name><name name-style="western"><surname>Banach</surname><given-names>M</given-names></name><name name-style="western"><surname>Johnston</surname><given-names>TP</given-names></name><name name-style="western"><surname>Sahebkar</surname><given-names>A</given-names></name></person-group><article-title>Phytochemicals: A potential therapeutic intervention for the prevention and treatment of cachexia</article-title><source>Clin. Nutr.</source><year>2022</year><volume>41</volume><fpage>2843</fpage><lpage>2857</lpage><pub-id pub-id-type="pmid">36403384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clnu.2022.11.009</pub-id></element-citation><mixed-citation id="mc-CR15" publication-type="journal">Zarifi, S. H., Bagherniya, M., Banach, M., Johnston, T. P. &amp; Sahebkar, A. Phytochemicals: A potential therapeutic intervention for the prevention and treatment of cachexia. <italic toggle="yes">Clin. Nutr.</italic><bold>41</bold>, 2843&#8211;2857 (2022).<pub-id pub-id-type="pmid">36403384</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.clnu.2022.11.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR16"><label>16.</label><citation-alternatives><element-citation id="ec-CR16" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Khatoon</surname><given-names>E</given-names></name><etal/></person-group><article-title>Phytochemicals in cancer cell chemosensitization: current knowledge and future perspectives</article-title><source>Semin Cancer Biol.</source><year>2022</year><volume>80</volume><fpage>306</fpage><lpage>339</lpage><pub-id pub-id-type="pmid">32610149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2020.06.014</pub-id></element-citation><mixed-citation id="mc-CR16" publication-type="journal">Khatoon, E. et al. Phytochemicals in cancer cell chemosensitization: Current knowledge and future perspectives. <italic toggle="yes">Semin. Cancer Biol.</italic><bold>80</bold>, 306&#8211;339 (2022).<pub-id pub-id-type="pmid">32610149</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2020.06.014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR17"><label>17.</label><citation-alternatives><element-citation id="ec-CR17" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moloudizargari</surname><given-names>M</given-names></name><etal/></person-group><article-title>Targeting Hippo signaling pathway by phytochemicals in cancer therapy</article-title><source>Semin Cancer Biol.</source><year>2022</year><volume>80</volume><fpage>183</fpage><lpage>194</lpage><pub-id pub-id-type="pmid">32428716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2020.05.005</pub-id></element-citation><mixed-citation id="mc-CR17" publication-type="journal">Moloudizargari, M. et al. Targeting Hippo signaling pathway by phytochemicals in cancer therapy. <italic toggle="yes">Semin. Cancer Biol.</italic><bold>80</bold>, 183&#8211;194 (2022).<pub-id pub-id-type="pmid">32428716</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2020.05.005</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR18"><label>18.</label><citation-alternatives><element-citation id="ec-CR18" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Islam</surname><given-names>MR</given-names></name><etal/></person-group><article-title>Colon cancer and colorectal cancer: prevention and treatment by potential natural products</article-title><source>Chem. Biol. Interact.</source><year>2022</year><volume>368</volume><fpage>110170</fpage><pub-id pub-id-type="pmid">36202214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2022.110170</pub-id></element-citation><mixed-citation id="mc-CR18" publication-type="journal">Islam, M. R. et al. Colon cancer and colorectal cancer: Prevention and treatment by potential natural products. <italic toggle="yes">Chem. Biol. Interact.</italic><bold>368</bold>, 110170 (2022).<pub-id pub-id-type="pmid">36202214</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.cbi.2022.110170</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR19"><label>19.</label><mixed-citation publication-type="other">Chen, J. T. Phytochemical omics in medicinal plants. <italic toggle="yes">Biomolecules</italic><bold>10</bold> (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/biom10060936</pub-id><pub-id pub-id-type="pmcid">PMC7356902</pub-id><pub-id pub-id-type="pmid">32575904</pub-id></mixed-citation></ref><ref id="CR20"><label>20.</label><citation-alternatives><element-citation id="ec-CR20" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Liang</surname><given-names>F</given-names></name><etal/></person-group><article-title>Molecular network and chemical fragment-based characteristics of medicinal herbs with cold and hot properties from Chinese medicine</article-title><source>J. Ethnopharmacol.</source><year>2013</year><volume>148</volume><fpage>770</fpage><lpage>779</lpage><pub-id pub-id-type="pmid">23702041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2013.04.055</pub-id></element-citation><mixed-citation id="mc-CR20" publication-type="journal">Liang, F. et al. Molecular network and chemical fragment-based characteristics of medicinal herbs with cold and hot properties from Chinese medicine. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>148</bold>, 770&#8211;779 (2013).<pub-id pub-id-type="pmid">23702041</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2013.04.055</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR21"><label>21.</label><citation-alternatives><element-citation id="ec-CR21" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>R</given-names></name><name name-style="western"><surname>Ma</surname><given-names>T</given-names></name><name name-style="western"><surname>Gu</surname><given-names>J</given-names></name><name name-style="western"><surname>Liang</surname><given-names>X</given-names></name><name name-style="western"><surname>Li</surname><given-names>S</given-names></name></person-group><article-title>Imbalanced network biomarkers for traditional Chinese medicine syndrome in gastritis patients</article-title><source>Sci. Rep.</source><year>2013</year><volume>3</volume><fpage>1543</fpage><pub-id pub-id-type="pmid">23529020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep01543</pub-id><pub-id pub-id-type="pmcid">PMC3607832</pub-id></element-citation><mixed-citation id="mc-CR21" publication-type="journal">Li, R., Ma, T., Gu, J., Liang, X. &amp; Li, S. Imbalanced network biomarkers for traditional Chinese medicine syndrome in gastritis patients. <italic toggle="yes">Sci. Rep.</italic><bold>3</bold>, 1543 (2013).<pub-id pub-id-type="pmid">23529020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/srep01543</pub-id><pub-id pub-id-type="pmcid">PMC3607832</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR22"><label>22.</label><citation-alternatives><element-citation id="ec-CR22" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><etal/></person-group><article-title>Traditional Chinese medicines differentially modulate the gut microbiota based on their nature (Yao-Xing)</article-title><source>Phytomedicine</source><year>2021</year><volume>85</volume><fpage>153496</fpage><pub-id pub-id-type="pmid">33714730</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2021.153496</pub-id></element-citation><mixed-citation id="mc-CR22" publication-type="journal">Zhang, X. et al. Traditional Chinese medicines differentially modulate the gut microbiota based on their nature (Yao-Xing). <italic toggle="yes">Phytomedicine</italic><bold>85</bold>, 153496 (2021).<pub-id pub-id-type="pmid">33714730</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2021.153496</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR23"><label>23.</label><citation-alternatives><element-citation id="ec-CR23" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fu</surname><given-names>X</given-names></name><etal/></person-group><article-title>Toward Understanding the cold, hot, and neutral nature of Chinese medicines using in Silico Mode-of-Action analysis</article-title><source>J. Chem. Inf. Model.</source><year>2017</year><volume>57</volume><fpage>468</fpage><lpage>483</lpage><pub-id pub-id-type="pmid">28257573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.6b00725</pub-id></element-citation><mixed-citation id="mc-CR23" publication-type="journal">Fu, X. et al. Toward understanding the cold, hot, and neutral nature of Chinese medicines using in silico mode-of-action analysis. <italic toggle="yes">J. Chem. Inf. Model.</italic><bold>57</bold>, 468&#8211;483 (2017).<pub-id pub-id-type="pmid">28257573</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.6b00725</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR24"><label>24.</label><citation-alternatives><element-citation id="ec-CR24" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>S</given-names></name><etal/></person-group><article-title>Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network</article-title><source>IET Syst. Biol.</source><year>2007</year><volume>1</volume><fpage>51</fpage><lpage>60</lpage><pub-id pub-id-type="pmid">17370429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1049/iet-syb:20060032</pub-id></element-citation><mixed-citation id="mc-CR24" publication-type="journal">Li, S. et al. Understanding ZHENG in traditional Chinese medicine in the context of neuro-endocrine-immune network. <italic toggle="yes">IET Syst. Biol.</italic><bold>1</bold>, 51&#8211;60 (2007).<pub-id pub-id-type="pmid">17370429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1049/iet-syb:20060032</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR25"><label>25.</label><citation-alternatives><element-citation id="ec-CR25" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>B</given-names></name></person-group><article-title>New insights into molecular mechanisms of cold or hot nature of food: when East Meets West</article-title><source>Food Res. Int.</source><year>2021</year><volume>144</volume><fpage>110361</fpage><pub-id pub-id-type="pmid">34053554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.foodres.2021.110361</pub-id></element-citation><mixed-citation id="mc-CR25" publication-type="journal">Zhou, Y. &amp; Xu, B. New insights into molecular mechanisms of cold or hot nature of food: When East Meets West. <italic toggle="yes">Food Res. Int.</italic><bold>144</bold>, 110361 (2021).<pub-id pub-id-type="pmid">34053554</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.foodres.2021.110361</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR26"><label>26.</label><mixed-citation publication-type="other">Zhu, Y. J. et al. Yin-Cold or Yang-Heat syndrome type of traditional Chinese medicine was associated with the epidermal growth factor receptor gene status in non-small cell lung cancer patients: Confirmation of a TCM concept. <italic toggle="yes">Evid. Based Complement. Alternat. Med.</italic><bold>2017</bold>, 7063859 (2017).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1155/2017/7063859</pub-id><pub-id pub-id-type="pmcid">PMC5292165</pub-id><pub-id pub-id-type="pmid">28203260</pub-id></mixed-citation></ref><ref id="CR27"><label>27.</label><citation-alternatives><element-citation id="ec-CR27" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kang</surname><given-names>L</given-names></name><name name-style="western"><surname>Tian</surname><given-names>Y</given-names></name><name name-style="western"><surname>Xu</surname><given-names>S</given-names></name><name name-style="western"><surname>Chen</surname><given-names>H</given-names></name></person-group><article-title>Oxaliplatin-induced peripheral neuropathy: clinical features, mechanisms, prevention and treatment</article-title><source>J. Neurol.</source><year>2021</year><volume>268</volume><fpage>3269</fpage><lpage>3282</lpage><pub-id pub-id-type="pmid">32474658</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-020-09942-w</pub-id></element-citation><mixed-citation id="mc-CR27" publication-type="journal">Kang, L., Tian, Y., Xu, S. &amp; Chen, H. Oxaliplatin-induced peripheral neuropathy: Clinical features, mechanisms, prevention and treatment. <italic toggle="yes">J. Neurol.</italic><bold>268</bold>, 3269&#8211;3282 (2021).<pub-id pub-id-type="pmid">32474658</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00415-020-09942-w</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR28"><label>28.</label><citation-alternatives><element-citation id="ec-CR28" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Guo</surname><given-names>JC</given-names></name><etal/></person-group><article-title>Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study</article-title><source>EBioMedicine</source><year>2020</year><volume>55</volume><fpage>102767</fpage><pub-id pub-id-type="pmid">32361251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2020.102767</pub-id><pub-id pub-id-type="pmcid">PMC7195527</pub-id></element-citation><mixed-citation id="mc-CR28" publication-type="journal">Guo, J. C. et al. Prognostic and predictive value of a five-molecule panel in resected pancreatic ductal adenocarcinoma: A multicentre study. <italic toggle="yes">EBioMedicine</italic><bold>55</bold>, 102767 (2020).<pub-id pub-id-type="pmid">32361251</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ebiom.2020.102767</pub-id><pub-id pub-id-type="pmcid">PMC7195527</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR29"><label>29.</label><mixed-citation publication-type="other">Zhang, P. et al. Network pharmacology: Towards the artificial intelligence-based precision traditional Chinese medicine. <italic toggle="yes">Brief Bioinform.</italic><bold>25</bold> (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbad518</pub-id><pub-id pub-id-type="pmcid">PMC10777171</pub-id><pub-id pub-id-type="pmid">38197310</pub-id></mixed-citation></ref><ref id="CR30"><label>30.</label><citation-alternatives><element-citation id="ec-CR30" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>X</given-names></name><name name-style="western"><surname>Qiu</surname><given-names>H</given-names></name><name name-style="western"><surname>Li</surname><given-names>C</given-names></name><name name-style="western"><surname>Cai</surname><given-names>P</given-names></name><name name-style="western"><surname>Qi</surname><given-names>F</given-names></name></person-group><article-title>The positive role of traditional Chinese medicine as an adjunctive therapy for cancer</article-title><source>Biosci. Trends</source><year>2021</year><volume>15</volume><fpage>283</fpage><lpage>298</lpage><pub-id pub-id-type="pmid">34421064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5582/bst.2021.01318</pub-id></element-citation><mixed-citation id="mc-CR30" publication-type="journal">Zhang, X., Qiu, H., Li, C., Cai, P. &amp; Qi, F. The positive role of traditional Chinese medicine as an adjunctive therapy for cancer. <italic toggle="yes">Biosci. Trends</italic>. <bold>15</bold>, 283&#8211;298 (2021).<pub-id pub-id-type="pmid">34421064</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.5582/bst.2021.01318</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR31"><label>31.</label><citation-alternatives><element-citation id="ec-CR31" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>M</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>D</given-names></name><name name-style="western"><surname>Yan</surname><given-names>J</given-names></name></person-group><article-title>Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases</article-title><source>Phytomedicine</source><year>2024</year><volume>130</volume><fpage>155738</fpage><pub-id pub-id-type="pmid">38824825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155738</pub-id></element-citation><mixed-citation id="mc-CR31" publication-type="journal">Xu, M., Zhang, D. &amp; Yan, J. Targeting ferroptosis using Chinese herbal compounds to treat respiratory diseases. <italic toggle="yes">Phytomedicine</italic><bold>130</bold>, 155738 (2024).<pub-id pub-id-type="pmid">38824825</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155738</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR32"><label>32.</label><citation-alternatives><element-citation id="ec-CR32" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kumar</surname><given-names>P</given-names></name><name name-style="western"><surname>Sharma</surname><given-names>R</given-names></name><name name-style="western"><surname>Garg</surname><given-names>N</given-names></name></person-group><article-title>Withania somnifera - a magic plant targeting multiple pathways in cancer related inflammation</article-title><source>Phytomedicine</source><year>2022</year><volume>101</volume><fpage>154137</fpage><pub-id pub-id-type="pmid">35533610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2022.154137</pub-id></element-citation><mixed-citation id="mc-CR32" publication-type="journal">Kumar, P., Sharma, R. &amp; Garg, N. Withania somnifera&#8212;a magic plant targeting multiple pathways in cancer related inflammation. <italic toggle="yes">Phytomedicine</italic><bold>101</bold>, 154137 (2022).<pub-id pub-id-type="pmid">35533610</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2022.154137</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR33"><label>33.</label><citation-alternatives><element-citation id="ec-CR33" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>He</surname><given-names>D</given-names></name><etal/></person-group><article-title>Lignan contents of Schisandra chinensis (Turcz.) baill. From different origins-A new model for evaluating the content of prominent components of Chinese herbs</article-title><source>Phytomedicine</source><year>2024</year><volume>128</volume><fpage>155361</fpage><pub-id pub-id-type="pmid">38552434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155361</pub-id></element-citation><mixed-citation id="mc-CR33" publication-type="journal">He, D. et al. Lignan contents of <italic toggle="yes">Schisandra chinensis</italic> (Turcz.) baill. from different origins&#8212;A new model for evaluating the content of prominent components of Chinese herbs. <italic toggle="yes">Phytomedicine</italic><bold>128</bold>, 155361 (2024).<pub-id pub-id-type="pmid">38552434</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155361</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR34"><label>34.</label><citation-alternatives><element-citation id="ec-CR34" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>ZJ</given-names></name><etal/></person-group><article-title>Artesunate synergizes with Sorafenib to induce ferroptosis in hepatocellular carcinoma</article-title><source>Acta Pharmacol. Sin</source><year>2021</year><volume>42</volume><fpage>301</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">32699265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41401-020-0478-3</pub-id><pub-id pub-id-type="pmcid">PMC8026986</pub-id></element-citation><mixed-citation id="mc-CR34" publication-type="journal">Li, Z. J. et al. Artesunate synergizes with Sorafenib to induce ferroptosis in hepatocellular carcinoma. <italic toggle="yes">Acta Pharmacol. Sin.</italic><bold>42</bold>, 301&#8211;310 (2021).<pub-id pub-id-type="pmid">32699265</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41401-020-0478-3</pub-id><pub-id pub-id-type="pmcid">PMC8026986</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR35"><label>35.</label><citation-alternatives><element-citation id="ec-CR35" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Efferth</surname><given-names>T</given-names></name></person-group><article-title>From ancient herb to modern drug: Artemisia annua and Artemisinin for cancer therapy</article-title><source>Semin Cancer Biol.</source><year>2017</year><volume>46</volume><fpage>65</fpage><lpage>83</lpage><pub-id pub-id-type="pmid">28254675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2017.02.009</pub-id></element-citation><mixed-citation id="mc-CR35" publication-type="journal">Efferth, T. From ancient herb to modern drug: Artemisia annua and Artemisinin for cancer therapy. <italic toggle="yes">Semin. Cancer Biol.</italic><bold>46</bold>, 65&#8211;83 (2017).<pub-id pub-id-type="pmid">28254675</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.semcancer.2017.02.009</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR36"><label>36.</label><citation-alternatives><element-citation id="ec-CR36" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zeng</surname><given-names>ZW</given-names></name><name name-style="western"><surname>Chen</surname><given-names>D</given-names></name><name name-style="western"><surname>Chen</surname><given-names>L</given-names></name><name name-style="western"><surname>He</surname><given-names>B</given-names></name><name name-style="western"><surname>Li</surname><given-names>Y</given-names></name></person-group><article-title>A comprehensive overview of Artemisinin and its derivatives as anticancer agents</article-title><source>Eur. J. Med. Chem.</source><year>2023</year><volume>247</volume><fpage>115000</fpage><pub-id pub-id-type="pmid">36538859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2022.115000</pub-id></element-citation><mixed-citation id="mc-CR36" publication-type="journal">Zeng, Z. W., Chen, D., Chen, L., He, B. &amp; Li, Y. A comprehensive overview of Artemisinin and its derivatives as anticancer agents. <italic toggle="yes">Eur. J. Med. Chem.</italic><bold>247</bold>, 115000 (2023).<pub-id pub-id-type="pmid">36538859</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ejmech.2022.115000</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR37"><label>37.</label><citation-alternatives><element-citation id="ec-CR37" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gao</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment</article-title><source>Adv. Drug Deliv Rev.</source><year>2022</year><volume>188</volume><fpage>114445</fpage><pub-id pub-id-type="pmid">35820601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addr.2022.114445</pub-id></element-citation><mixed-citation id="mc-CR37" publication-type="journal">Gao, Q. et al. Opportunities and challenges for co-delivery nanomedicines based on combination of phytochemicals with chemotherapeutic drugs in cancer treatment. <italic toggle="yes">Adv. Drug Deliv. Rev.</italic><bold>188</bold>, 114445 (2022).<pub-id pub-id-type="pmid">35820601</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.addr.2022.114445</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR38"><label>38.</label><citation-alternatives><element-citation id="ec-CR38" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Maji</surname><given-names>A</given-names></name><etal/></person-group><article-title>Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal</article-title><source>Nature</source><year>2023</year><volume>623</volume><fpage>1079</fpage><lpage>1085</lpage><pub-id pub-id-type="pmid">37938782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-06710-4</pub-id><pub-id pub-id-type="pmcid">PMC10883201</pub-id></element-citation><mixed-citation id="mc-CR38" publication-type="journal">Maji, A. et al. Tuning sterol extraction kinetics yields a renal-sparing polyene antifungal. <italic toggle="yes">Nature</italic><bold>623</bold>, 1079&#8211;1085 (2023).<pub-id pub-id-type="pmid">37938782</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41586-023-06710-4</pub-id><pub-id pub-id-type="pmcid">PMC10883201</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR39"><label>39.</label><citation-alternatives><element-citation id="ec-CR39" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mullowney</surname><given-names>MW</given-names></name><etal/></person-group><article-title>Artificial intelligence for natural product drug discovery</article-title><source>Nat. Rev. Drug Discov</source><year>2023</year><volume>22</volume><fpage>895</fpage><lpage>916</lpage><pub-id pub-id-type="pmid">37697042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41573-023-00774-7</pub-id></element-citation><mixed-citation id="mc-CR39" publication-type="journal">Mullowney, M. W. et al. Artificial intelligence for natural product drug discovery. <italic toggle="yes">Nat. Rev. Drug Discov.</italic><bold>22</bold>, 895&#8211;916 (2023).<pub-id pub-id-type="pmid">37697042</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41573-023-00774-7</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR40"><label>40.</label><citation-alternatives><element-citation id="ec-CR40" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ni</surname><given-names>M</given-names></name><etal/></person-group><article-title>Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe<sup>2+</sup> accumulation</article-title><source>Phytomedicine</source><year>2023</year><volume>112</volume><fpage>154701</fpage><pub-id pub-id-type="pmid">36773431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2023.154701</pub-id></element-citation><mixed-citation id="mc-CR40" publication-type="journal">Ni, M. et al. Shikonin and cisplatin synergistically overcome cisplatin resistance of ovarian cancer by inducing ferroptosis via upregulation of HMOX1 to promote Fe<sup>2+</sup> accumulation. <italic toggle="yes">Phytomedicine</italic><bold>112</bold>, 154701 (2023).<pub-id pub-id-type="pmid">36773431</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2023.154701</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR41"><label>41.</label><citation-alternatives><element-citation id="ec-CR41" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schmidt</surname><given-names>KT</given-names></name><etal/></person-group><article-title>A Single-arm phase II study combining NLG207, a nanoparticle camptothecin, with enzalutamide in advanced metastatic Castration-resistant prostate Cancer Post-Enzalutamide</article-title><source>Oncologist</source><year>2022</year><volume>27</volume><fpage>718</fpage><lpage>e694</lpage><pub-id pub-id-type="pmid">35640474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/oncolo/oyac100</pub-id><pub-id pub-id-type="pmcid">PMC9438911</pub-id></element-citation><mixed-citation id="mc-CR41" publication-type="journal">Schmidt, K. T. et al. A single-arm phase II study combining NLG207, a nanoparticle camptothecin, with enzalutamide in advanced metastatic castration-resistant prostate cancer post-enzalutamide. <italic toggle="yes">Oncologist</italic><bold>27</bold>, 718&#8211;e694 (2022).<pub-id pub-id-type="pmid">35640474</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/oncolo/oyac100</pub-id><pub-id pub-id-type="pmcid">PMC9438911</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR42"><label>42.</label><citation-alternatives><element-citation id="ec-CR42" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Golden</surname><given-names>EB</given-names></name><etal/></person-group><article-title>Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors</article-title><source>Blood</source><year>2009</year><volume>113</volume><fpage>5927</fpage><lpage>5937</lpage><pub-id pub-id-type="pmid">19190249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2008-07-171389</pub-id></element-citation><mixed-citation id="mc-CR42" publication-type="journal">Golden, E. B. et al. Green tea polyphenols block the anticancer effects of bortezomib and other boronic acid-based proteasome inhibitors. <italic toggle="yes">Blood</italic><bold>113</bold>, 5927&#8211;5937 (2009).<pub-id pub-id-type="pmid">19190249</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1182/blood-2008-07-171389</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR43"><label>43.</label><mixed-citation publication-type="other">Orzetti, S. &amp; Baldo, P. Toxicity derived from interaction between natural compounds and Cancer therapeutic drugs metabolized by CYP3A4: Lessons learned from two clinical case reports. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>24</bold> (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms242115976</pub-id><pub-id pub-id-type="pmcid">PMC10648905</pub-id><pub-id pub-id-type="pmid">37958959</pub-id></mixed-citation></ref><ref id="CR44"><label>44.</label><citation-alternatives><element-citation id="ec-CR44" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Caesar</surname><given-names>LK</given-names></name><name name-style="western"><surname>Cech</surname><given-names>NB</given-names></name></person-group><article-title>Synergy and antagonism in natural product extracts: when 1 + 1 does not equal 2</article-title><source>Nat. Prod. Rep.</source><year>2019</year><volume>36</volume><fpage>869</fpage><lpage>888</lpage><pub-id pub-id-type="pmid">31187844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c9np00011a</pub-id><pub-id pub-id-type="pmcid">PMC6820002</pub-id></element-citation><mixed-citation id="mc-CR44" publication-type="journal">Caesar, L. K. &amp; Cech, N. B. Synergy and antagonism in natural product extracts: When 1 + 1 does not equal 2. <italic toggle="yes">Nat. Prod. Rep.</italic><bold>36</bold>, 869&#8211;888 (2019).<pub-id pub-id-type="pmid">31187844</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/c9np00011a</pub-id><pub-id pub-id-type="pmcid">PMC6820002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR45"><label>45.</label><citation-alternatives><element-citation id="ec-CR45" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fang</surname><given-names>S</given-names></name><etal/></person-group><article-title>HERB: a high-throughput experiment- and reference-guided database of traditional Chinese medicine</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D1197</fpage><lpage>D1206</lpage><pub-id pub-id-type="pmid">33264402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa1063</pub-id><pub-id pub-id-type="pmcid">PMC7779036</pub-id></element-citation><mixed-citation id="mc-CR45" publication-type="journal">Fang, S. et al. HERB: A high-throughput experiment- and reference-guided database of traditional Chinese medicine. <italic toggle="yes">Nucleic Acids Res.</italic><bold>49</bold>, D1197&#8211;D1206 (2021).<pub-id pub-id-type="pmid">33264402</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa1063</pub-id><pub-id pub-id-type="pmcid">PMC7779036</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR46"><label>46.</label><citation-alternatives><element-citation id="ec-CR46" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wu</surname><given-names>Y</given-names></name><etal/></person-group><article-title>SymMap: an integrative database of traditional Chinese medicine enhanced by symptom mapping</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>47</volume><fpage>D1110</fpage><lpage>D1117</lpage><pub-id pub-id-type="pmid">30380087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gky1021</pub-id><pub-id pub-id-type="pmcid">PMC6323958</pub-id></element-citation><mixed-citation id="mc-CR46" publication-type="journal">Wu, Y. et al. SymMap: An integrative database of traditional Chinese medicine enhanced by symptom mapping. <italic toggle="yes">Nucleic Acids Res.</italic><bold>47</bold>, D1110&#8211;D1117 (2019).<pub-id pub-id-type="pmid">30380087</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gky1021</pub-id><pub-id pub-id-type="pmcid">PMC6323958</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR47"><label>47.</label><citation-alternatives><element-citation id="ec-CR47" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yan</surname><given-names>D</given-names></name><etal/></person-group><article-title>HIT 2.0: an enhanced platform for herbal ingredients&#8217; targets</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D1238</fpage><lpage>D1243</lpage><pub-id pub-id-type="pmid">34986599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1011</pub-id><pub-id pub-id-type="pmcid">PMC8728248</pub-id></element-citation><mixed-citation id="mc-CR47" publication-type="journal">Yan, D. et al. HIT 2.0: An enhanced platform for herbal ingredients&#8217; targets. <italic toggle="yes">Nucleic Acids Res.</italic><bold>50</bold>, D1238&#8211;D1243 (2022).<pub-id pub-id-type="pmid">34986599</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1011</pub-id><pub-id pub-id-type="pmcid">PMC8728248</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR48"><label>48.</label><citation-alternatives><element-citation id="ec-CR48" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>ETCM v2.0: an update with comprehensive resource and rich annotations for traditional Chinese medicine</article-title><source>Acta Pharm. Sinica B</source><year>2023</year><volume>13</volume><fpage>2559</fpage><lpage>2571</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apsb.2023.03.012</pub-id><pub-id pub-id-type="pmcid">PMC10326295</pub-id><pub-id pub-id-type="pmid">37425046</pub-id></element-citation><mixed-citation id="mc-CR48" publication-type="journal">Zhang, Y. et al. ETCM v2.0: An update with comprehensive resource and rich annotations for traditional Chinese medicine. <italic toggle="yes">Acta Pharm. Sin. B</italic><bold>13</bold>, 2559&#8211;2571 (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.apsb.2023.03.012</pub-id><pub-id pub-id-type="pmcid">PMC10326295</pub-id><pub-id pub-id-type="pmid">37425046</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR49"><label>49.</label><citation-alternatives><element-citation id="ec-CR49" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Lv</surname><given-names>Q</given-names></name><etal/></person-group><article-title>TCMBank: bridges between the largest herbal medicines, chemical ingredients, target proteins, and associated diseases with intelligence text mining</article-title><source>Chem. Sci.</source><year>2023</year><volume>14</volume><fpage>10684</fpage><lpage>10701</lpage><pub-id pub-id-type="pmid">37829020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d3sc02139d</pub-id><pub-id pub-id-type="pmcid">PMC10566508</pub-id></element-citation><mixed-citation id="mc-CR49" publication-type="journal">Lv, Q. et al. TCMBank: Bridges between the largest herbal medicines, chemical ingredients, target proteins, and associated diseases with intelligence text mining. <italic toggle="yes">Chem. Sci.</italic><bold>14</bold>, 10684&#8211;10701 (2023).<pub-id pub-id-type="pmid">37829020</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1039/d3sc02139d</pub-id><pub-id pub-id-type="pmcid">PMC10566508</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR50"><label>50.</label><citation-alternatives><element-citation id="ec-CR50" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xu</surname><given-names>H</given-names></name><etal/></person-group><article-title>Systematic description of the content variation of natural products (NPs): to prompt the yield of High-Value NPs and the discovery of new therapeutics</article-title><source>J. Chem. Inf. Model.</source><year>2023</year><volume>63</volume><fpage>1615</fpage><lpage>1625</lpage><pub-id pub-id-type="pmid">36795011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.2c01459</pub-id></element-citation><mixed-citation id="mc-CR50" publication-type="journal">Xu, H. et al. Systematic description of the content variation of natural products (NPs): To prompt the yield of High-Value NPs and the discovery of new therapeutics. <italic toggle="yes">J. Chem. Inf. Model.</italic><bold>63</bold>, 1615&#8211;1625 (2023).<pub-id pub-id-type="pmid">36795011</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.2c01459</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR51"><label>51.</label><citation-alternatives><element-citation id="ec-CR51" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wishart</surname><given-names>DS</given-names></name><etal/></person-group><article-title>NP-MRD: the natural products magnetic resonance database</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D665</fpage><lpage>D677</lpage><pub-id pub-id-type="pmid">34791429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1052</pub-id><pub-id pub-id-type="pmcid">PMC8728158</pub-id></element-citation><mixed-citation id="mc-CR51" publication-type="journal">Wishart, D. S. et al. NP-MRD: The natural products magnetic resonance database. <italic toggle="yes">Nucleic Acids Res.</italic><bold>50</bold>, D665&#8211;D677 (2022).<pub-id pub-id-type="pmid">34791429</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1052</pub-id><pub-id pub-id-type="pmcid">PMC8728158</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR52"><label>52.</label><citation-alternatives><element-citation id="ec-CR52" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gallo</surname><given-names>K</given-names></name><etal/></person-group><article-title>SuperNatural 3.0-a database of natural products and natural product-based derivatives</article-title><source>Nucleic Acids Res.</source><year>2023</year><volume>51</volume><fpage>D654</fpage><lpage>D659</lpage><pub-id pub-id-type="pmid">36399452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkac1008</pub-id><pub-id pub-id-type="pmcid">PMC9825600</pub-id></element-citation><mixed-citation id="mc-CR52" publication-type="journal">Gallo, K. et al. SuperNatural 3.0-a database of natural products and natural product-based derivatives. <italic toggle="yes">Nucleic Acids Res.</italic><bold>51</bold>, D654&#8211;D659 (2023).<pub-id pub-id-type="pmid">36399452</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkac1008</pub-id><pub-id pub-id-type="pmcid">PMC9825600</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR53"><label>53.</label><citation-alternatives><element-citation id="ec-CR53" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>L</given-names></name><etal/></person-group><article-title>TCMID 2.0: a comprehensive resource for TCM</article-title><source>Nucleic Acids Res.</source><year>2018</year><volume>46</volume><fpage>D1117</fpage><lpage>D1120</lpage><pub-id pub-id-type="pmid">29106634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkx1028</pub-id><pub-id pub-id-type="pmcid">PMC5753259</pub-id></element-citation><mixed-citation id="mc-CR53" publication-type="journal">Huang, L. et al. TCMID 2.0: A comprehensive resource for TCM. <italic toggle="yes">Nucleic Acids Res.</italic><bold>46</bold>, D1117&#8211;D1120 (2018).<pub-id pub-id-type="pmid">29106634</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkx1028</pub-id><pub-id pub-id-type="pmcid">PMC5753259</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR54"><label>54.</label><citation-alternatives><element-citation id="ec-CR54" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sorokina</surname><given-names>M</given-names></name><name name-style="western"><surname>Merseburger</surname><given-names>P</given-names></name><name name-style="western"><surname>Rajan</surname><given-names>K</given-names></name><name name-style="western"><surname>Yirik</surname><given-names>MA</given-names></name><name name-style="western"><surname>Steinbeck</surname><given-names>C</given-names></name></person-group><article-title>COCONUT online: collection of open natural products database</article-title><source>J. Cheminform</source><year>2021</year><volume>13</volume><fpage>2</fpage><pub-id pub-id-type="pmid">33423696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13321-020-00478-9</pub-id><pub-id pub-id-type="pmcid">PMC7798278</pub-id></element-citation><mixed-citation id="mc-CR54" publication-type="journal">Sorokina, M., Merseburger, P., Rajan, K., Yirik, M. A. &amp; Steinbeck, C. COCONUT online: Collection of open natural products database. <italic toggle="yes">J. Cheminform.</italic><bold>13</bold>, 2 (2021).<pub-id pub-id-type="pmid">33423696</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13321-020-00478-9</pub-id><pub-id pub-id-type="pmcid">PMC7798278</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR55"><label>55.</label><citation-alternatives><element-citation id="ec-CR55" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Moumbock</surname><given-names>AFA</given-names></name><etal/></person-group><article-title>StreptomeDB 3.0: an updated compendium of streptomycetes natural products</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D600</fpage><lpage>D604</lpage><pub-id pub-id-type="pmid">33051671</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa868</pub-id><pub-id pub-id-type="pmcid">PMC7779017</pub-id></element-citation><mixed-citation id="mc-CR55" publication-type="journal">Moumbock, A. F. A. et al. StreptomeDB 3.0: An updated compendium of streptomycetes natural products. <italic toggle="yes">Nucleic Acids Res.</italic><bold>49</bold>, D600&#8211;D604 (2021).<pub-id pub-id-type="pmid">33051671</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa868</pub-id><pub-id pub-id-type="pmcid">PMC7779017</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR56"><label>56.</label><citation-alternatives><element-citation id="ec-CR56" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zdobnov</surname><given-names>EM</given-names></name><etal/></person-group><article-title>OrthoDB v9.1: cataloging evolutionary and functional annotations for animal, fungal, plant, archaeal, bacterial and viral orthologs</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>D744</fpage><lpage>D749</lpage><pub-id pub-id-type="pmid">27899580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw1119</pub-id><pub-id pub-id-type="pmcid">PMC5210582</pub-id></element-citation><mixed-citation id="mc-CR56" publication-type="journal">Zdobnov, E. M. et al. OrthoDB v9.1: Cataloging evolutionary and functional annotations for animal, fungal, plant, archaeal, bacterial and viral orthologs. <italic toggle="yes">Nucleic Acids Res.</italic><bold>45</bold>, D744&#8211;D749 (2017).<pub-id pub-id-type="pmid">27899580</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw1119</pub-id><pub-id pub-id-type="pmcid">PMC5210582</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR57"><label>57.</label><citation-alternatives><element-citation id="ec-CR57" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>van Santen</surname><given-names>JA</given-names></name><etal/></person-group><article-title>The natural products atlas 2.0: a database of microbially-derived natural products</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D1317</fpage><lpage>D1323</lpage><pub-id pub-id-type="pmid">34718710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab941</pub-id><pub-id pub-id-type="pmcid">PMC8728154</pub-id></element-citation><mixed-citation id="mc-CR57" publication-type="journal">van Santen, J. A. et al. The natural products atlas 2.0: A database of microbially-derived natural products. <italic toggle="yes">Nucleic Acids Res.</italic><bold>50</bold>, D1317&#8211;D1323 (2022).<pub-id pub-id-type="pmid">34718710</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab941</pub-id><pub-id pub-id-type="pmcid">PMC8728154</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR58"><label>58.</label><citation-alternatives><element-citation id="ec-CR58" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiong</surname><given-names>G</given-names></name><etal/></person-group><article-title>DDInter: an online drug-drug interaction database towards improving clinical decision-making and patient safety</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D1200</fpage><lpage>D1207</lpage><pub-id pub-id-type="pmid">34634800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab880</pub-id><pub-id pub-id-type="pmcid">PMC8728114</pub-id></element-citation><mixed-citation id="mc-CR58" publication-type="journal">Xiong, G. et al. DDInter: An online drug-drug interaction database towards improving clinical decision-making and patient safety. <italic toggle="yes">Nucleic Acids Res.</italic><bold>50</bold>, D1200&#8211;D1207 (2022).<pub-id pub-id-type="pmid">34634800</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab880</pub-id><pub-id pub-id-type="pmcid">PMC8728114</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR59"><label>59.</label><citation-alternatives><element-citation id="ec-CR59" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>X</given-names></name><etal/></person-group><article-title>NPCDR: natural product-based drug combination and its disease-specific molecular regulation</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D1324</fpage><lpage>D1333</lpage><pub-id pub-id-type="pmid">34664659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab913</pub-id><pub-id pub-id-type="pmcid">PMC8728151</pub-id></element-citation><mixed-citation id="mc-CR59" publication-type="journal">Sun, X. et al. NPCDR: Natural product-based drug combination and its disease-specific molecular regulation. <italic toggle="yes">Nucleic Acids Res.</italic><bold>50</bold>, D1324&#8211;D1333 (2022).<pub-id pub-id-type="pmid">34664659</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab913</pub-id><pub-id pub-id-type="pmcid">PMC8728151</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR60"><label>60.</label><mixed-citation publication-type="other">Hong, Y. et al. DDID: A comprehensive resource for visualization and analysis of diet-drug interactions. <italic toggle="yes">Brief Bioinform.</italic><bold>25</bold> (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbae212</pub-id><pub-id pub-id-type="pmcid">PMC11074590</pub-id><pub-id pub-id-type="pmid">38711369</pub-id></mixed-citation></ref><ref id="CR61"><label>61.</label><citation-alternatives><element-citation id="ec-CR61" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Knox</surname><given-names>C</given-names></name><etal/></person-group><article-title>DrugBank 6.0: the drugbank knowledgebase for 2024</article-title><source>Nucleic Acids Res.</source><year>2024</year><volume>52</volume><fpage>D1265</fpage><lpage>D1275</lpage><pub-id pub-id-type="pmid">37953279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad976</pub-id><pub-id pub-id-type="pmcid">PMC10767804</pub-id></element-citation><mixed-citation id="mc-CR61" publication-type="journal">Knox, C. et al. DrugBank 6.0: The drugbank knowledgebase for 2024. <italic toggle="yes">Nucleic Acids Res.</italic><bold>52</bold>, D1265&#8211;D1275 (2024).<pub-id pub-id-type="pmid">37953279</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad976</pub-id><pub-id pub-id-type="pmcid">PMC10767804</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR62"><label>62.</label><mixed-citation publication-type="other">Chen, L. et al. Luteolin enhances transepithelial sodium transport in the lung alveolar model: Integrating network Pharmacology and mechanism study. <italic toggle="yes">Int. J. Mol. Sci.</italic><bold>24</bold> (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms241210122</pub-id><pub-id pub-id-type="pmcid">PMC10299022</pub-id><pub-id pub-id-type="pmid">37373270</pub-id></mixed-citation></ref><ref id="CR63"><label>63.</label><citation-alternatives><element-citation id="ec-CR63" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Therapeutic target database describing target druggability information</article-title><source>Nucleic Acids Res.</source><year>2024</year><volume>52</volume><fpage>D1465</fpage><lpage>D1477</lpage><pub-id pub-id-type="pmid">37713619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad751</pub-id><pub-id pub-id-type="pmcid">PMC10767903</pub-id></element-citation><mixed-citation id="mc-CR63" publication-type="journal">Zhou, Y. et al. Therapeutic target database describing target druggability information. <italic toggle="yes">Nucleic Acids Res.</italic><bold>52</bold>, D1465&#8211;D1477 (2024).<pub-id pub-id-type="pmid">37713619</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad751</pub-id><pub-id pub-id-type="pmcid">PMC10767903</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR64"><label>64.</label><citation-alternatives><element-citation id="ec-CR64" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mistry</surname><given-names>J</given-names></name><etal/></person-group><article-title>Pfam: the protein families database in 2021</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D412</fpage><lpage>D419</lpage><pub-id pub-id-type="pmid">33125078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa913</pub-id><pub-id pub-id-type="pmcid">PMC7779014</pub-id></element-citation><mixed-citation id="mc-CR64" publication-type="journal">Mistry, J. et al. Pfam: The protein families database in 2021. <italic toggle="yes">Nucleic Acids Res.</italic><bold>49</bold>, D412&#8211;D419 (2021).<pub-id pub-id-type="pmid">33125078</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa913</pub-id><pub-id pub-id-type="pmcid">PMC7779014</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR65"><label>65.</label><citation-alternatives><element-citation id="ec-CR65" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanehisa</surname><given-names>M</given-names></name><name name-style="western"><surname>Furumichi</surname><given-names>M</given-names></name><name name-style="western"><surname>Tanabe</surname><given-names>M</given-names></name><name name-style="western"><surname>Sato</surname><given-names>Y</given-names></name><name name-style="western"><surname>Morishima</surname><given-names>K</given-names></name></person-group><article-title>KEGG: new perspectives on genomes, pathways, diseases and drugs</article-title><source>Nucleic Acids Res.</source><year>2017</year><volume>45</volume><fpage>D353</fpage><lpage>D361</lpage><pub-id pub-id-type="pmid">27899662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw1092</pub-id><pub-id pub-id-type="pmcid">PMC5210567</pub-id></element-citation><mixed-citation id="mc-CR65" publication-type="journal">Kanehisa, M., Furumichi, M., Tanabe, M., Sato, Y. &amp; Morishima, K. KEGG: New perspectives on genomes, pathways, diseases and drugs. <italic toggle="yes">Nucleic Acids Res.</italic><bold>45</bold>, D353&#8211;D361 (2017).<pub-id pub-id-type="pmid">27899662</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkw1092</pub-id><pub-id pub-id-type="pmcid">PMC5210567</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR66"><label>66.</label><citation-alternatives><element-citation id="ec-CR66" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Brown</surname><given-names>GR</given-names></name><etal/></person-group><article-title>Gene: a gene-centered information resource at NCBI</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>D36</fpage><lpage>D42</lpage><pub-id pub-id-type="pmid">25355515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1055</pub-id><pub-id pub-id-type="pmcid">PMC4383897</pub-id></element-citation><mixed-citation id="mc-CR66" publication-type="journal">Brown, G. R. et al. Gene: A gene-centered information resource at NCBI. <italic toggle="yes">Nucleic Acids Res.</italic><bold>43</bold>, D36&#8211;D42 (2015).<pub-id pub-id-type="pmid">25355515</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1055</pub-id><pub-id pub-id-type="pmcid">PMC4383897</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR67"><label>67.</label><citation-alternatives><element-citation id="ec-CR67" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bairoch</surname><given-names>A</given-names></name></person-group><article-title>The cellosaurus, a Cell-Line knowledge resource</article-title><source>J. Biomol. Tech.</source><year>2018</year><volume>29</volume><fpage>25</fpage><lpage>38</lpage><pub-id pub-id-type="pmid">29805321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7171/jbt.18-2902-002</pub-id><pub-id pub-id-type="pmcid">PMC5945021</pub-id></element-citation><mixed-citation id="mc-CR67" publication-type="journal">Bairoch, A. The cellosaurus, a cell-line knowledge resource. <italic toggle="yes">J. Biomol. Tech.</italic><bold>29</bold>, 25&#8211;38 (2018).<pub-id pub-id-type="pmid">29805321</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7171/jbt.18-2902-002</pub-id><pub-id pub-id-type="pmcid">PMC5945021</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR68"><label>68.</label><citation-alternatives><element-citation id="ec-CR68" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Saier</surname><given-names>MH</given-names></name><etal/></person-group><article-title>The transporter classification database (TCDB): 2021 update</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D461</fpage><lpage>D467</lpage><pub-id pub-id-type="pmid">33170213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa1004</pub-id><pub-id pub-id-type="pmcid">PMC7778945</pub-id></element-citation><mixed-citation id="mc-CR68" publication-type="journal">Saier, M. H. et al. The transporter classification database (TCDB): 2021 update. <italic toggle="yes">Nucleic Acids Res.</italic><bold>49</bold>, D461&#8211;D467 (2021).<pub-id pub-id-type="pmid">33170213</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa1004</pub-id><pub-id pub-id-type="pmcid">PMC7778945</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR69"><label>69.</label><citation-alternatives><element-citation id="ec-CR69" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mendez</surname><given-names>D</given-names></name><etal/></person-group><article-title>ChEMBL: towards direct deposition of bioassay data</article-title><source>Nucleic Acids Res.</source><year>2019</year><volume>47</volume><fpage>D930</fpage><lpage>D940</lpage><pub-id pub-id-type="pmid">30398643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gky1075</pub-id><pub-id pub-id-type="pmcid">PMC6323927</pub-id></element-citation><mixed-citation id="mc-CR69" publication-type="journal">Mendez, D. et al. ChEMBL: Towards direct deposition of bioassay data. <italic toggle="yes">Nucleic Acids Res.</italic><bold>47</bold>, D930&#8211;D940 (2019).<pub-id pub-id-type="pmid">30398643</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gky1075</pub-id><pub-id pub-id-type="pmcid">PMC6323927</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR70"><label>70.</label><citation-alternatives><element-citation id="ec-CR70" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kim</surname><given-names>S</given-names></name><etal/></person-group><article-title>PubChem in 2021: new data content and improved web interfaces</article-title><source>Nucleic Acids Res.</source><year>2021</year><volume>49</volume><fpage>D1388</fpage><lpage>D1395</lpage><pub-id pub-id-type="pmid">33151290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa971</pub-id><pub-id pub-id-type="pmcid">PMC7778930</pub-id></element-citation><mixed-citation id="mc-CR70" publication-type="journal">Kim, S. et al. PubChem in 2021: New data content and improved web interfaces. <italic toggle="yes">Nucleic Acids Res.</italic><bold>49</bold>, D1388&#8211;D1395 (2021).<pub-id pub-id-type="pmid">33151290</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkaa971</pub-id><pub-id pub-id-type="pmcid">PMC7778930</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR71"><label>71.</label><citation-alternatives><element-citation id="ec-CR71" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Harding</surname><given-names>SD</given-names></name><etal/></person-group><article-title>The IUPHAR/BPS guide to PHARMACOLOGY in 2024</article-title><source>Nucleic Acids Res.</source><year>2024</year><volume>52</volume><fpage>D1438</fpage><lpage>D1449</lpage><pub-id pub-id-type="pmid">37897341</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad944</pub-id><pub-id pub-id-type="pmcid">PMC10767925</pub-id></element-citation><mixed-citation id="mc-CR71" publication-type="journal">Harding, S. D. et al. The IUPHAR/BPS guide to PHARMACOLOGY in 2024. <italic toggle="yes">Nucleic Acids Res.</italic><bold>52</bold>, D1438&#8211;D1449 (2024).<pub-id pub-id-type="pmid">37897341</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkad944</pub-id><pub-id pub-id-type="pmcid">PMC10767925</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR72"><label>72.</label><citation-alternatives><element-citation id="ec-CR72" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Li</surname><given-names>M</given-names></name><etal/></person-group><article-title>Exploring the biochemical basis of the meridian tropism theory for the Qi-Invigorating traditional Chinese medicine herb Panax ginseng</article-title><source>J. evidence-based Integr. Med.</source><year>2021</year><volume>26</volume><fpage>2515690x20983249</fpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2515690X20983249</pub-id><pub-id pub-id-type="pmcid">PMC7917415</pub-id><pub-id pub-id-type="pmid">33634715</pub-id></element-citation><mixed-citation id="mc-CR72" publication-type="journal">Li, M. et al. Exploring the biochemical basis of the meridian tropism theory for the Qi-Invigorating traditional Chinese medicine herb Panax ginseng. <italic toggle="yes">J. Evid. Based Integr. Med.</italic><bold>26</bold>, 2515690x20983249 (2021).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1177/2515690X20983249</pub-id><pub-id pub-id-type="pmcid">PMC7917415</pub-id><pub-id pub-id-type="pmid">33634715</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR73"><label>73.</label><citation-alternatives><element-citation id="ec-CR73" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cai</surname><given-names>MC</given-names></name><etal/></person-group><article-title>ADReCS: an ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>D907</fpage><lpage>D913</lpage><pub-id pub-id-type="pmid">25361966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1066</pub-id><pub-id pub-id-type="pmcid">PMC4383906</pub-id></element-citation><mixed-citation id="mc-CR73" publication-type="journal">Cai, M. C. et al. ADReCS: An ontology database for aiding standardization and hierarchical classification of adverse drug reaction terms. <italic toggle="yes">Nucleic Acids Res.</italic><bold>43</bold>, D907&#8211;D913 (2015).<pub-id pub-id-type="pmid">25361966</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1066</pub-id><pub-id pub-id-type="pmcid">PMC4383906</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR74"><label>74.</label><citation-alternatives><element-citation id="ec-CR74" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Huang</surname><given-names>LH</given-names></name><etal/></person-group><article-title>ADReCS-Target: target profiles for aiding drug safety research and application</article-title><source>Nucleic Acids Res.</source><year>2018</year><volume>46</volume><fpage>D911</fpage><lpage>D917</lpage><pub-id pub-id-type="pmid">30053268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkx899</pub-id><pub-id pub-id-type="pmcid">PMC5753178</pub-id></element-citation><mixed-citation id="mc-CR74" publication-type="journal">Huang, L. H. et al. ADReCS-target: Target profiles for aiding drug safety research and application. <italic toggle="yes">Nucleic Acids Res.</italic><bold>46</bold>, D911&#8211;D917 (2018).<pub-id pub-id-type="pmid">30053268</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkx899</pub-id><pub-id pub-id-type="pmcid">PMC5753178</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR75"><label>75.</label><citation-alternatives><element-citation id="ec-CR75" publication-type="journal"><person-group person-group-type="author"><collab>The Lancet</collab></person-group><article-title>ICD-11</article-title><source>Lancet</source><year>2019</year><volume>393</volume><fpage>2275</fpage><pub-id pub-id-type="pmid">31180012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(19)31205-X</pub-id></element-citation><mixed-citation id="mc-CR75" publication-type="journal">The Lancet. ICD-11. <italic toggle="yes">Lancet</italic><bold>393</bold>, 2275 (2019).<pub-id pub-id-type="pmid">31180012</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0140-6736(19)31205-X</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR76"><label>76.</label><citation-alternatives><element-citation id="ec-CR76" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Stobaugh</surname><given-names>RE</given-names></name></person-group><article-title>Chemical abstracts service chemical registry system. 11. Substance-related statistics: update and additions</article-title><source>J. Chem. Inf. Comput. Sci.</source><year>1988</year><volume>28</volume><fpage>180</fpage><lpage>187</lpage><pub-id pub-id-type="pmid">3235472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/ci00060a003</pub-id></element-citation><mixed-citation id="mc-CR76" publication-type="journal">Stobaugh, R. E. Chemical abstracts service chemical registry system. 11. Substance-related statistics: Update and additions. <italic toggle="yes">J. Chem. Inf. Comput. Sci.</italic><bold>28</bold>, 180&#8211;187 (1988).<pub-id pub-id-type="pmid">3235472</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/ci00060a003</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR77"><label>77.</label><citation-alternatives><element-citation id="ec-CR77" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tse</surname><given-names>T</given-names></name><name name-style="western"><surname>Fain</surname><given-names>KM</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>DA</given-names></name></person-group><article-title>How to avoid common problems when using clinicaltrials.gov in research: 10 issues to consider</article-title><source>BMJ</source><year>2018</year><volume>361</volume><fpage>k1452</fpage><pub-id pub-id-type="pmid">29802130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.k1452</pub-id><pub-id pub-id-type="pmcid">PMC5968400</pub-id></element-citation><mixed-citation id="mc-CR77" publication-type="journal">Tse, T., Fain, K. M. &amp; Zarin, D. A. How to avoid common problems when using clinicaltrials.gov in research: 10 issues to consider. <italic toggle="yes">BMJ</italic><bold>361</bold>, k1452 (2018).<pub-id pub-id-type="pmid">29802130</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/bmj.k1452</pub-id><pub-id pub-id-type="pmcid">PMC5968400</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR78"><label>78.</label><citation-alternatives><element-citation id="ec-CR78" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schwartz</surname><given-names>LM</given-names></name><name name-style="western"><surname>Woloshin</surname><given-names>S</given-names></name><name name-style="western"><surname>Zheng</surname><given-names>E</given-names></name><name name-style="western"><surname>Tse</surname><given-names>T</given-names></name><name name-style="western"><surname>Zarin</surname><given-names>DA</given-names></name></person-group><article-title>ClinicalTrials.gov and drugs@fda: A comparison of results reporting for new drug approval trials</article-title><source>Ann. Intern. Med.</source><year>2016</year><volume>165</volume><fpage>421</fpage><lpage>430</lpage><pub-id pub-id-type="pmid">27294570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M15-2658</pub-id><pub-id pub-id-type="pmcid">PMC5028264</pub-id></element-citation><mixed-citation id="mc-CR78" publication-type="journal">Schwartz, L. M., Woloshin, S., Zheng, E., Tse, T. &amp; Zarin, D. A. ClinicalTrials.gov and drugs@fda: A comparison of results reporting for new drug approval trials. <italic toggle="yes">Ann. Intern. Med.</italic><bold>165</bold>, 421&#8211;430 (2016).<pub-id pub-id-type="pmid">27294570</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7326/M15-2658</pub-id><pub-id pub-id-type="pmcid">PMC5028264</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR79"><label>79.</label><citation-alternatives><element-citation id="ec-CR79" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Goodman</surname><given-names>JM</given-names></name><name name-style="western"><surname>Pletnev</surname><given-names>I</given-names></name><name name-style="western"><surname>Thiessen</surname><given-names>P</given-names></name><name name-style="western"><surname>Bolton</surname><given-names>E</given-names></name><name name-style="western"><surname>Heller</surname><given-names>SR</given-names></name></person-group><article-title>R. InChI version 1.06: now more than 99.99% reliable</article-title><source>J. Cheminform</source><year>2021</year><volume>13</volume><fpage>40</fpage><pub-id pub-id-type="pmid">34030732</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13321-021-00517-z</pub-id><pub-id pub-id-type="pmcid">PMC8147039</pub-id></element-citation><mixed-citation id="mc-CR79" publication-type="journal">Goodman, J. M., Pletnev, I., Thiessen, P., Bolton, E. &amp; Heller, S. R. InChI version 1.06: Now more than 99.99% reliable. <italic toggle="yes">J. Cheminform.</italic><bold>13</bold>, 40 (2021).<pub-id pub-id-type="pmid">34030732</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s13321-021-00517-z</pub-id><pub-id pub-id-type="pmcid">PMC8147039</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR80"><label>80.</label><citation-alternatives><element-citation id="ec-CR80" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sayers</surname><given-names>EW</given-names></name><etal/></person-group><article-title>Database resources of the National center for biotechnology information</article-title><source>Nucleic Acids Res.</source><year>2022</year><volume>50</volume><fpage>D20</fpage><lpage>D26</lpage><pub-id pub-id-type="pmid">34850941</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1112</pub-id><pub-id pub-id-type="pmcid">PMC8728269</pub-id></element-citation><mixed-citation id="mc-CR80" publication-type="journal">Sayers, E. W. et al. Database resources of the National center for biotechnology information. <italic toggle="yes">Nucleic Acids Res.</italic><bold>50</bold>, D20&#8211;D26 (2022).<pub-id pub-id-type="pmid">34850941</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gkab1112</pub-id><pub-id pub-id-type="pmcid">PMC8728269</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR81"><label>81.</label><citation-alternatives><element-citation id="ec-CR81" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Federhen</surname><given-names>S</given-names></name></person-group><article-title>Type material in the NCBI taxonomy database</article-title><source>Nucleic Acids Res.</source><year>2015</year><volume>43</volume><fpage>D1086</fpage><lpage>D1098</lpage><pub-id pub-id-type="pmid">25398905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1127</pub-id><pub-id pub-id-type="pmcid">PMC4383940</pub-id></element-citation><mixed-citation id="mc-CR81" publication-type="journal">Federhen, S. Type material in the NCBI taxonomy database. <italic toggle="yes">Nucleic Acids Res.</italic><bold>43</bold>, D1086&#8211;D1098 (2015).<pub-id pub-id-type="pmid">25398905</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/nar/gku1127</pub-id><pub-id pub-id-type="pmcid">PMC4383940</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR82"><label>82.</label><citation-alternatives><element-citation id="ec-CR82" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tian</surname><given-names>W</given-names></name><etal/></person-group><article-title>Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism</article-title><source>Pharmacol. Res.</source><year>2024</year><volume>199</volume><fpage>107034</fpage><pub-id pub-id-type="pmid">38070793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2023.107034</pub-id></element-citation><mixed-citation id="mc-CR82" publication-type="journal">Tian, W. et al. Harnessing natural product polysaccharides against lung cancer and revisit its novel mechanism. <italic toggle="yes">Pharmacol. Res.</italic><bold>199</bold>, 107034 (2024).<pub-id pub-id-type="pmid">38070793</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phrs.2023.107034</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR83"><label>83.</label><citation-alternatives><element-citation id="ec-CR83" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Pei</surname><given-names>T</given-names></name><etal/></person-group><article-title>Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS(2) technology</article-title><source>J. Ethnopharmacol.</source><year>2023</year><volume>306</volume><fpage>116134</fpage><pub-id pub-id-type="pmid">36627003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116134</pub-id></element-citation><mixed-citation id="mc-CR83" publication-type="journal">Pei, T. et al. Yupingfeng San exhibits anticancer effect in hepatocellular carcinoma cells via the MAPK pathway revealed by HTS(2) technology. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>306</bold>, 116134 (2023).<pub-id pub-id-type="pmid">36627003</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116134</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR84"><label>84.</label><citation-alternatives><element-citation id="ec-CR84" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>J</given-names></name><etal/></person-group><article-title>Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism</article-title><source>Phytomedicine</source><year>2024</year><volume>129</volume><fpage>155600</fpage><pub-id pub-id-type="pmid">38614043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155600</pub-id></element-citation><mixed-citation id="mc-CR84" publication-type="journal">Zhang, J. et al. Natural products and derivatives for breast cancer treatment: from drug discovery to molecular mechanism. <italic toggle="yes">Phytomedicine</italic><bold>129</bold>, 155600 (2024).<pub-id pub-id-type="pmid">38614043</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155600</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR85"><label>85.</label><citation-alternatives><element-citation id="ec-CR85" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xiang</surname><given-names>ZD</given-names></name><etal/></person-group><article-title>Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity</article-title><source>Phytomedicine</source><year>2024</year><volume>126</volume><fpage>155444</fpage><pub-id pub-id-type="pmid">38367423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155444</pub-id></element-citation><mixed-citation id="mc-CR85" publication-type="journal">Xiang, Z. D. et al. Protoberberine alkaloids: A review of the gastroprotective effects, pharmacokinetics, and toxicity. <italic toggle="yes">Phytomedicine</italic><bold>126</bold>, 155444 (2024).<pub-id pub-id-type="pmid">38367423</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155444</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR86"><label>86.</label><citation-alternatives><element-citation id="ec-CR86" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>Huaier enhances the tumor-killing effect and reverses gemcitabine-induced stemness by suppressing FoxM1</article-title><source>Phytomedicine</source><year>2024</year><volume>129</volume><fpage>155656</fpage><pub-id pub-id-type="pmid">38723529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155656</pub-id></element-citation><mixed-citation id="mc-CR86" publication-type="journal">Wang, Q. et al. Huaier enhances the tumor-killing effect and reverses gemcitabine-induced stemness by suppressing FoxM1. <italic toggle="yes">Phytomedicine</italic><bold>129</bold>, 155656 (2024).<pub-id pub-id-type="pmid">38723529</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.phymed.2024.155656</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR87"><label>87.</label><citation-alternatives><element-citation id="ec-CR87" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid Sphingomyelinase</article-title><source>Mol. Ther.</source><year>2023</year><volume>31</volume><fpage>2169</fpage><lpage>2187</lpage><pub-id pub-id-type="pmid">37211762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2023.05.015</pub-id><pub-id pub-id-type="pmcid">PMC10362416</pub-id></element-citation><mixed-citation id="mc-CR87" publication-type="journal">Wang, Y. et al. Polyphyllin D punctures hypertrophic lysosomes to reverse drug resistance of hepatocellular carcinoma by targeting acid Sphingomyelinase. <italic toggle="yes">Mol. Ther.</italic><bold>31</bold>, 2169&#8211;2187 (2023).<pub-id pub-id-type="pmid">37211762</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ymthe.2023.05.015</pub-id><pub-id pub-id-type="pmcid">PMC10362416</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR88"><label>88.</label><citation-alternatives><element-citation id="ec-CR88" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tang</surname><given-names>Q</given-names></name><etal/></person-group><article-title>FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma</article-title><source>J. Ethnopharmacol.</source><year>2024</year><volume>318</volume><fpage>116646</fpage><pub-id pub-id-type="pmid">37269912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116646</pub-id></element-citation><mixed-citation id="mc-CR88" publication-type="journal">Tang, Q. et al. FZKA reverses gefitinib resistance by regulating EZH2/Snail/EGFR signaling pathway in lung adenocarcinoma. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>318</bold>, 116646 (2024).<pub-id pub-id-type="pmid">37269912</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116646</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR89"><label>89.</label><citation-alternatives><element-citation id="ec-CR89" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Wang</surname><given-names>S</given-names></name><etal/></person-group><article-title>Research progress of traditional Chinese medicine monomers in reversing multidrug resistance of breast Cancer</article-title><source>Am. J. Chin. Med.</source><year>2023</year><volume>51</volume><fpage>575</fpage><lpage>594</lpage><pub-id pub-id-type="pmid">36823097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1142/S0192415X23500283</pub-id></element-citation><mixed-citation id="mc-CR89" publication-type="journal">Wang, S. et al. Research progress of traditional Chinese medicine monomers in reversing multidrug resistance of breast Cancer. <italic toggle="yes">Am. J. Chin. Med.</italic><bold>51</bold>, 575&#8211;594 (2023).<pub-id pub-id-type="pmid">36823097</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1142/S0192415X23500283</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR90"><label>90.</label><mixed-citation publication-type="other">Casas, A. I. et al. From single drug targets to synergistic network pharmacology in ischemic stroke. <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic><bold>116</bold>, 7129&#8211;7136 (2019).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.1820799116</pub-id><pub-id pub-id-type="pmcid">PMC6452748</pub-id><pub-id pub-id-type="pmid">30894481</pub-id></mixed-citation></ref><ref id="CR91"><label>91.</label><citation-alternatives><element-citation id="ec-CR91" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhao</surname><given-names>L</given-names></name><etal/></person-group><article-title>Network Pharmacology, a promising approach to reveal the Pharmacology mechanism of Chinese medicine formula</article-title><source>J. Ethnopharmacol.</source><year>2023</year><volume>309</volume><fpage>116306</fpage><pub-id pub-id-type="pmid">36858276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116306</pub-id></element-citation><mixed-citation id="mc-CR91" publication-type="journal">Zhao, L. et al. Network pharmacology, a promising approach to reveal the pharmacology mechanism of Chinese medicine formula. <italic toggle="yes">J. Ethnopharmacol.</italic><bold>309</bold>, 116306 (2023).<pub-id pub-id-type="pmid">36858276</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jep.2023.116306</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR92"><label>92.</label><mixed-citation publication-type="other">Hight, S. K. et al. High-throughput functional annotation of natural products by integrated activity profiling. <italic toggle="yes">Proc. Natl. Acad. Sci. U. S. A.</italic><bold>119</bold>, e2208458119 (2022).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1073/pnas.2208458119</pub-id><pub-id pub-id-type="pmcid">PMC9894231</pub-id><pub-id pub-id-type="pmid">36449542</pub-id></mixed-citation></ref><ref id="CR93"><label>93.</label><citation-alternatives><element-citation id="ec-CR93" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Fabricant</surname><given-names>DS</given-names></name><name name-style="western"><surname>Farnsworth</surname><given-names>NR</given-names></name></person-group><article-title>The value of plants used in traditional medicine for drug discovery</article-title><source>Environ. Health Perspect.</source><year>2001</year><volume>109</volume><issue>Suppl 1</issue><fpage>69</fpage><lpage>75</lpage><pub-id pub-id-type="pmid">11250806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.01109s169</pub-id><pub-id pub-id-type="pmcid">PMC1240543</pub-id></element-citation><mixed-citation id="mc-CR93" publication-type="journal">Fabricant, D. S. &amp; Farnsworth, N. R. The value of plants used in traditional medicine for drug discovery. <italic toggle="yes">Environ. Health Perspect.</italic><bold>109</bold>(Suppl 1), 69&#8211;75 (2001).<pub-id pub-id-type="pmid">11250806</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1289/ehp.01109s169</pub-id><pub-id pub-id-type="pmcid">PMC1240543</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR94"><label>94.</label><citation-alternatives><element-citation id="ec-CR94" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Qin</surname><given-names>T</given-names></name><etal/></person-group><article-title>The role of Curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective</article-title><source>Crit. Rev. Food Sci. Nutr.</source><year>2024</year><volume>64</volume><fpage>8822</fpage><lpage>8851</lpage><pub-id pub-id-type="pmid">37096460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10408398.2023.2204349</pub-id></element-citation><mixed-citation id="mc-CR94" publication-type="journal">Qin, T. et al. The role of Curcumin in the liver-gut system diseases: from mechanisms to clinical therapeutic perspective. <italic toggle="yes">Crit. Rev. Food Sci. Nutr.</italic><bold>64</bold>, 8822&#8211;8851 (2024).<pub-id pub-id-type="pmid">37096460</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1080/10408398.2023.2204349</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR95"><label>95.</label><citation-alternatives><element-citation id="ec-CR95" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Theodoridis</surname><given-names>S</given-names></name><name name-style="western"><surname>Drakou</surname><given-names>EG</given-names></name><name name-style="western"><surname>Hickler</surname><given-names>T</given-names></name><name name-style="western"><surname>Thines</surname><given-names>M</given-names></name><name name-style="western"><surname>Nogues-Bravo</surname><given-names>D</given-names></name></person-group><article-title>Evaluating natural medicinal resources and their exposure to global change</article-title><source>Lancet Planet. Health</source><year>2023</year><volume>7</volume><fpage>e155</fpage><lpage>e163</lpage><pub-id pub-id-type="pmid">36754471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2542-5196(22)00317-5</pub-id></element-citation><mixed-citation id="mc-CR95" publication-type="journal">Theodoridis, S., Drakou, E. G., Hickler, T., Thines, M. &amp; Nogues-Bravo, D. Evaluating natural medicinal resources and their exposure to global change. <italic toggle="yes">Lancet Planet. Health</italic><bold>7</bold>, e155&#8211;e163 (2023).<pub-id pub-id-type="pmid">36754471</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S2542-5196(22)00317-5</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR96"><label>96.</label><mixed-citation publication-type="other">Gao, Q. et al. Honokiol-magnolol-baicalin possesses synergistic anticancer potential and enhances the efficacy of anti-PD-1 immunotherapy in colorectal cancer by triggering GSDME-dependent pyroptosis. <italic toggle="yes">Adv. Sci.</italic><bold>12</bold>, e2417022 (2025).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/advs.202417022</pub-id><pub-id pub-id-type="pmcid">PMC11967828</pub-id><pub-id pub-id-type="pmid">39950759</pub-id></mixed-citation></ref><ref id="CR97"><label>97.</label><mixed-citation publication-type="other">Choi, Y. et al. Novel insights into paclitaxel&#8217;s role on tumor-associated macrophages in enhancing PD-1 blockade in breast cancer treatment. <italic toggle="yes">J. Immunother. Cancer</italic><bold>12</bold> (2024).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1136/jitc-2024-008864</pub-id><pub-id pub-id-type="pmcid">PMC11253755</pub-id><pub-id pub-id-type="pmid">39009452</pub-id></mixed-citation></ref><ref id="CR98"><label>98.</label><citation-alternatives><element-citation id="ec-CR98" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shi</surname><given-names>HX</given-names></name><etal/></person-group><article-title>Targeting DKK1 enhances the antitumor activity of Paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer</article-title><source>Mol. Cancer</source><year>2024</year><volume>23</volume><fpage>152</fpage><pub-id pub-id-type="pmid">39085861</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12943-024-02067-y</pub-id><pub-id pub-id-type="pmcid">PMC11290233</pub-id></element-citation><mixed-citation id="mc-CR98" publication-type="journal">Shi, H. X. et al. Targeting DKK1 enhances the antitumor activity of Paclitaxel and alleviates chemotherapy-induced peripheral neuropathy in breast cancer. <italic toggle="yes">Mol. Cancer</italic><bold>23</bold>, 152 (2024).<pub-id pub-id-type="pmid">39085861</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1186/s12943-024-02067-y</pub-id><pub-id pub-id-type="pmcid">PMC11290233</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR99"><label>99.</label><citation-alternatives><element-citation id="ec-CR99" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Colombo</surname><given-names>N</given-names></name><etal/></person-group><article-title>Relacorilant+ nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: a three-arm, randomized, controlled, open-label phase II study</article-title><source>J. Clin. Oncol.</source><year>2023</year><volume>41</volume><fpage>4779</fpage><lpage>4789</lpage><pub-id pub-id-type="pmid">37364223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.22.02624</pub-id><pub-id pub-id-type="pmcid">PMC10602497</pub-id></element-citation><mixed-citation id="mc-CR99" publication-type="journal">Colombo, N. et al. Relacorilant+ nab-paclitaxel in patients with recurrent, platinum-resistant ovarian cancer: A three-arm, randomized, controlled, open-label phase II study. <italic toggle="yes">J. Clin. Oncol.</italic><bold>41</bold>, 4779&#8211;4789 (2023).<pub-id pub-id-type="pmid">37364223</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1200/JCO.22.02624</pub-id><pub-id pub-id-type="pmcid">PMC10602497</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR100"><label>100.</label><citation-alternatives><element-citation id="ec-CR100" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yu</surname><given-names>P</given-names></name><etal/></person-group><article-title>Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for Paclitaxel treatment</article-title><source>Nat. Commun.</source><year>2024</year><volume>15</volume><fpage>3771</fpage><pub-id pub-id-type="pmid">38704377</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48144-0</pub-id><pub-id pub-id-type="pmcid">PMC11069556</pub-id></element-citation><mixed-citation id="mc-CR100" publication-type="journal">Yu, P. et al. Mutation characteristics and molecular evolution of ovarian metastasis from gastric cancer and potential biomarkers for Paclitaxel treatment. <italic toggle="yes">Nat. Commun.</italic><bold>15</bold>, 3771 (2024).<pub-id pub-id-type="pmid">38704377</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1038/s41467-024-48144-0</pub-id><pub-id pub-id-type="pmcid">PMC11069556</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR101"><label>101.</label><mixed-citation publication-type="other">Liang, F. et al. Elucidation of the final steps in taxol biosynthesis and its biotechnological production. <italic toggle="yes">Nat. Synth.</italic> (2025).</mixed-citation></ref><ref id="CR102"><label>102.</label><citation-alternatives><element-citation id="ec-CR102" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><name name-style="western"><surname>Zhang</surname><given-names>YD</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>P</given-names></name><name name-style="western"><surname>Huang</surname><given-names>SM</given-names></name></person-group><article-title>Predicting drug-drug interactions: an FDA perspective</article-title><source>AAPS J.</source><year>2009</year><volume>11</volume><fpage>300</fpage><lpage>306</lpage><pub-id pub-id-type="pmid">19418230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1208/s12248-009-9106-3</pub-id><pub-id pub-id-type="pmcid">PMC2691466</pub-id></element-citation><mixed-citation id="mc-CR102" publication-type="journal">Zhang, L., Zhang, Y. D., Zhao, P. &amp; Huang, S. M. Predicting drug-drug interactions: An FDA perspective. <italic toggle="yes">AAPS J.</italic><bold>11</bold>, 300&#8211;306 (2009).<pub-id pub-id-type="pmid">19418230</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1208/s12248-009-9106-3</pub-id><pub-id pub-id-type="pmcid">PMC2691466</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR103"><label>103.</label><citation-alternatives><element-citation id="ec-CR103" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Tornio</surname><given-names>A</given-names></name><name name-style="western"><surname>Filppula</surname><given-names>AM</given-names></name><name name-style="western"><surname>Niemi</surname><given-names>M</given-names></name><name name-style="western"><surname>Backman</surname><given-names>JT</given-names></name></person-group><article-title>Clinical studies on Drug-Drug interactions involving metabolism and transport: methodology, pitfalls, and interpretation</article-title><source>Clin. Pharmacol. Ther.</source><year>2019</year><volume>105</volume><fpage>1345</fpage><lpage>1361</lpage><pub-id pub-id-type="pmid">30916389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpt.1435</pub-id><pub-id pub-id-type="pmcid">PMC6563007</pub-id></element-citation><mixed-citation id="mc-CR103" publication-type="journal">Tornio, A., Filppula, A. M., Niemi, M. &amp; Backman, J. T. Clinical studies on Drug-Drug interactions involving metabolism and transport: Methodology, pitfalls, and interpretation. <italic toggle="yes">Clin. Pharmacol. Ther.</italic><bold>105</bold>, 1345&#8211;1361 (2019).<pub-id pub-id-type="pmid">30916389</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpt.1435</pub-id><pub-id pub-id-type="pmcid">PMC6563007</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR104"><label>104.</label><citation-alternatives><element-citation id="ec-CR104" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ashrafizadeh</surname><given-names>M</given-names></name><etal/></person-group><article-title>Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with Paclitaxel and alleviation of its adverse effects</article-title><source>Life Sci.</source><year>2020</year><volume>256</volume><fpage>117984</fpage><pub-id pub-id-type="pmid">32593707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.117984</pub-id></element-citation><mixed-citation id="mc-CR104" publication-type="journal">Ashrafizadeh, M. et al. Curcumin in cancer therapy: A novel adjunct for combination chemotherapy with Paclitaxel and alleviation of its adverse effects. <italic toggle="yes">Life Sci.</italic><bold>256</bold>, 117984 (2020).<pub-id pub-id-type="pmid">32593707</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.lfs.2020.117984</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR105"><label>105.</label><citation-alternatives><element-citation id="ec-CR105" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Hosseini</surname><given-names>M</given-names></name><etal/></person-group><article-title>Therapeutic potential of Curcumin in treatment of pancreatic cancer: current status and future perspectives</article-title><source>J. Cell. Biochem.</source><year>2017</year><volume>118</volume><fpage>1634</fpage><lpage>1638</lpage><pub-id pub-id-type="pmid">28106283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcb.25897</pub-id></element-citation><mixed-citation id="mc-CR105" publication-type="journal">Hosseini, M. et al. Therapeutic potential of Curcumin in treatment of pancreatic cancer: Current status and future perspectives. <italic toggle="yes">J. Cell. Biochem.</italic><bold>118</bold>, 1634&#8211;1638 (2017).<pub-id pub-id-type="pmid">28106283</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/jcb.25897</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR106"><label>106.</label><citation-alternatives><element-citation id="ec-CR106" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhou</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis</article-title><source>Phytother Res.</source><year>2023</year><volume>37</volume><fpage>5837</fpage><lpage>5853</lpage><pub-id pub-id-type="pmid">37621136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ptr.7990</pub-id></element-citation><mixed-citation id="mc-CR106" publication-type="journal">Zhou, Y. et al. Epigallocatechin gallate circumvents drug-induced resistance in non-small-cell lung cancer by modulating glucose metabolism and AMPK/AKT/MAPK axis. <italic toggle="yes">Phytother. Res.</italic><bold>37</bold>, 5837&#8211;5853 (2023).<pub-id pub-id-type="pmid">37621136</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/ptr.7990</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR107"><label>107.</label><citation-alternatives><element-citation id="ec-CR107" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kanai</surname><given-names>M</given-names></name><etal/></person-group><article-title>A phase I/II study of gemcitabine-based chemotherapy plus Curcumin for patients with gemcitabine-resistant pancreatic cancer</article-title><source>Cancer Chemother. Pharmacol.</source><year>2011</year><volume>68</volume><fpage>157</fpage><lpage>164</lpage><pub-id pub-id-type="pmid">20859741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00280-010-1470-2</pub-id></element-citation><mixed-citation id="mc-CR107" publication-type="journal">Kanai, M. et al. A phase I/II study of gemcitabine-based chemotherapy plus Curcumin for patients with gemcitabine-resistant pancreatic cancer. <italic toggle="yes">Cancer Chemother. Pharmacol.</italic><bold>68</bold>, 157&#8211;164 (2011).<pub-id pub-id-type="pmid">20859741</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00280-010-1470-2</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR108"><label>108.</label><citation-alternatives><element-citation id="ec-CR108" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Bayet-Robert</surname><given-names>M</given-names></name><etal/></person-group><article-title>Phase I dose escalation trial of docetaxel plus Curcumin in patients with advanced and metastatic breast cancer</article-title><source>Cancer Biol. Ther.</source><year>2010</year><volume>9</volume><fpage>8</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">19901561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/cbt.9.1.10392</pub-id></element-citation><mixed-citation id="mc-CR108" publication-type="journal">Bayet-Robert, M. et al. Phase I dose escalation trial of docetaxel plus Curcumin in patients with advanced and metastatic breast cancer. <italic toggle="yes">Cancer Biol. Ther.</italic><bold>9</bold>, 8&#8211;14 (2010).<pub-id pub-id-type="pmid">19901561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.4161/cbt.9.1.10392</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR109"><label>109.</label><citation-alternatives><element-citation id="ec-CR109" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Yang</surname><given-names>CQ</given-names></name><etal/></person-group><article-title>Maintaining calcium homeostasis as a strategy to alleviate nephrotoxicity caused by Evodiamine</article-title><source>Ecotoxicol. Environ. Saf.</source><year>2024</year><volume>281</volume><fpage>116563</fpage><pub-id pub-id-type="pmid">38878560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ecoenv.2024.116563</pub-id></element-citation><mixed-citation id="mc-CR109" publication-type="journal">Yang, C. Q. et al. Maintaining calcium homeostasis as a strategy to alleviate nephrotoxicity caused by Evodiamine. <italic toggle="yes">Ecotoxicol. Environ. Saf.</italic><bold>281</bold>, 116563 (2024).<pub-id pub-id-type="pmid">38878560</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.ecoenv.2024.116563</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR110"><label>110.</label><citation-alternatives><element-citation id="ec-CR110" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Scuto</surname><given-names>M</given-names></name><etal/></person-group><article-title>Redox modulation of vitagenes via plant polyphenols and vitamin D: novel insights for chemoprevention and therapeutic interventions based on organoid technology</article-title><source>Mech. Ageing Dev.</source><year>2021</year><volume>199</volume><fpage>111551</fpage><pub-id pub-id-type="pmid">34358533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mad.2021.111551</pub-id></element-citation><mixed-citation id="mc-CR110" publication-type="journal">Scuto, M. et al. Redox modulation of vitagenes via plant polyphenols and vitamin D: Novel insights for chemoprevention and therapeutic interventions based on organoid technology. <italic toggle="yes">Mech. Ageing Dev.</italic><bold>199</bold>, 111551 (2021).<pub-id pub-id-type="pmid">34358533</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.mad.2021.111551</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR111"><label>111.</label><mixed-citation publication-type="other">Lekota, M., Modisane, K. J., Apostolides, Z. &amp; van der Waals, J. E. Metabolomic fingerprinting of potato cultivars differing in susceptibility to <italic toggle="yes">Spongospora subterranea</italic> f. Sp. subterranea root infection. <italic toggle="yes">Int J. Mol. Sci.</italic><bold>21</bold> (2020).<pub-id pub-id-type="doi" assigning-authority="pmc">10.3390/ijms21113788</pub-id><pub-id pub-id-type="pmcid">PMC7312161</pub-id><pub-id pub-id-type="pmid">32471154</pub-id></mixed-citation></ref><ref id="CR112"><label>112.</label><citation-alternatives><element-citation id="ec-CR112" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>L</given-names></name><etal/></person-group><article-title>Toxic and active material basis of Aconitum sinomontanum Nakai based on biological activity guidance and UPLC-Q/TOF-MS technology</article-title><source>J. Pharm. Biomed. Anal.</source><year>2020</year><volume>188</volume><fpage>113374</fpage><pub-id pub-id-type="pmid">32563055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpba.2020.113374</pub-id></element-citation><mixed-citation id="mc-CR112" publication-type="journal">Zhang, L. et al. Toxic and active material basis of <italic toggle="yes">Aconitum sinomontanum</italic> Nakai based on biological activity guidance and UPLC-Q/TOF-MS technology. <italic toggle="yes">J. Pharm. Biomed. Anal.</italic><bold>188</bold>, 113374 (2020).<pub-id pub-id-type="pmid">32563055</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.jpba.2020.113374</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR113"><label>113.</label><citation-alternatives><element-citation id="ec-CR113" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Xie</surname><given-names>J</given-names></name><etal/></person-group><article-title>Nanotechnology for the delivery of phytochemicals in cancer therapy</article-title><source>Biotechnol. Adv.</source><year>2016</year><volume>34</volume><fpage>343</fpage><lpage>353</lpage><pub-id pub-id-type="pmid">27071534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biotechadv.2016.04.002</pub-id></element-citation><mixed-citation id="mc-CR113" publication-type="journal">Xie, J. et al. Nanotechnology for the delivery of phytochemicals in cancer therapy. <italic toggle="yes">Biotechnol. Adv.</italic><bold>34</bold>, 343&#8211;353 (2016).<pub-id pub-id-type="pmid">27071534</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/j.biotechadv.2016.04.002</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR114"><label>114.</label><citation-alternatives><element-citation id="ec-CR114" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zhang</surname><given-names>Y</given-names></name><name name-style="western"><surname>Deng</surname><given-names>Z</given-names></name><name name-style="western"><surname>Xu</surname><given-names>X</given-names></name><name name-style="western"><surname>Feng</surname><given-names>Y</given-names></name><name name-style="western"><surname>Junliang</surname><given-names>S</given-names></name></person-group><article-title>Application of artificial intelligence in Drug-Drug interactions prediction: A review</article-title><source>J. Chem. Inf. Model.</source><year>2024</year><volume>64</volume><fpage>2158</fpage><lpage>2173</lpage><pub-id pub-id-type="pmid">37458400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.3c00582</pub-id></element-citation><mixed-citation id="mc-CR114" publication-type="journal">Zhang, Y., Deng, Z., Xu, X., Feng, Y. &amp; Junliang, S. Application of artificial intelligence in Drug-Drug interactions prediction: A review. <italic toggle="yes">J. Chem. Inf. Model.</italic><bold>64</bold>, 2158&#8211;2173 (2024).<pub-id pub-id-type="pmid">37458400</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.jcim.3c00582</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR115"><label>115.</label><mixed-citation publication-type="other">Lin, X. et al. Comprehensive evaluation of deep and graph learning on drug-drug interactions prediction. <italic toggle="yes">Brief Bioinform.</italic><bold>24</bold> (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbad235</pub-id><pub-id pub-id-type="pmid">37401373</pub-id></mixed-citation></ref><ref id="CR116"><label>116.</label><citation-alternatives><element-citation id="ec-CR116" publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sun</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Inhibitory effects of alkaloids on OATP1B1 in vitro and in vivo: prediction for Food/Herb-Drug interactions and hepatoprotective effects based on Structure-Activity relationships</article-title><source>Chem. Res. Toxicol.</source><year>2025</year><volume>38</volume><fpage>281</fpage><lpage>295</lpage><pub-id pub-id-type="pmid">39899883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrestox.4c00418</pub-id></element-citation><mixed-citation id="mc-CR116" publication-type="journal">Sun, Y. et al. Inhibitory effects of alkaloids on OATP1B1 in vitro and in vivo: Prediction for Food/Herb-Drug interactions and hepatoprotective effects based on Structure-Activity relationships. <italic toggle="yes">Chem. Res. Toxicol.</italic><bold>38</bold>, 281&#8211;295 (2025).<pub-id pub-id-type="pmid">39899883</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1021/acs.chemrestox.4c00418</pub-id></mixed-citation></citation-alternatives></ref><ref id="CR117"><label>117.</label><mixed-citation publication-type="other">Gan, Y., Liu, W., Xu, G., Yan, C. &amp; Zou, G. DMFDDI: Deep multimodal fusion for drug-drug interaction prediction. <italic toggle="yes">Brief Bioinform.</italic><bold>24</bold> (2023).<pub-id pub-id-type="doi" assigning-authority="pmc">10.1093/bib/bbad397</pub-id><pub-id pub-id-type="pmid">37930025</pub-id></mixed-citation></ref></ref-list></back></article></pmc-articleset>